1
|
Murciano G, Bartoletti F, Lopez G, Sansoni A. CLINICAL AND DIAGNOSTIC EVALUATIONS IN A CASE OF AORTIC THROMBOEMBOLISM IN A FERRET. J Exot Pet Med 2023. [DOI: 10.1053/j.jepm.2023.02.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/06/2023]
|
2
|
Secor A, Zhao S, Wei L, Das P, Haddad T, Miah A, Spakowicz D, Lopez G, Husain M, Grogan M, Li M, Schweitzer C, Pilcher C, Uribe D, Cheng G, Phelps M, Guo J, Shields P, He K, Bertino E, Carbone D, Otterson G, Presley C, Owen D. PP01.25 Incidence and Timing of Immune-Related Adverse Events in Patients With Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitor as Monotherapy or in Combination With Chemotherapy. J Thorac Oncol 2023. [DOI: 10.1016/j.jtho.2022.09.051] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/29/2023]
|
3
|
Murphy S, O'Donoghue ML, Wiviott S, Atar D, Keech AC, Kuder J, Im K, Flores-Arredondo J, Antonio J, Lopez G, Elliott M, Wang B, Monsalvo ML, Abbasi SA, Giugliano RP, Sabatine MS. REDUCTION IN TOTAL CARDIOVASCULAR EVENTS WITH THE PCSK9 INHIBITOR EVOLOCUMAB IN PATIENTS WITH CARDIOVASCULAR DISEASE IN THE COMBINED FOURIER AND FOURIER OPEN-LABEL EXTENSION (OLE) STUDIES. J Am Coll Cardiol 2023. [DOI: 10.1016/s0735-1097(23)01565-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 03/06/2023]
|
4
|
O'Donoghue ML, Rosenson RS, Gencer B, Antonio J, Lopez G, Lepor NE, Gaudet D, Baum SJ, Stout E, Knusel B, Kuder J, Ran X, Murphy S, Wu Y, Wang H, Kassahun H, Sabatine MS. ASSOCIATION OF BASELINE LIPOPROTEIN(A) AND PERCENTAGE OF LIPOPROTEIN(A) LOWERING WITH OLPASIRAN. J Am Coll Cardiol 2023. [DOI: 10.1016/s0735-1097(23)01574-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 03/06/2023]
|
5
|
Hidalgo AI, Ulloa-Leal C, Gajardo G, Lopez G, Ratto M. 229 The presence of an embryo in the uterine horn of llamas produces a variation in the concentration of inflammatory cytokines of uterine fluid. Reprod Fertil Dev 2022. [DOI: 10.1071/rdv35n2ab229] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022] Open
|
6
|
Li M, Zhao S, Guo J, Gauntner T, Schafer J, Chakravarthy K, Lopez G, Secor A, Das P, Surya N, Husain M, Patel S, Grogan M, Spakowicz D, Miah A, Wei L, He K, Bertino E, Alahmadi A, Memmott R, Kaufman J, Presley C, Shields P, Carbone D, Otterson G, Owen D. EP08.01-062 Body Mass Index, Immune Related Adverse Events, and Survival in Patients with Metastatic Non-small Cell Lung Cancer Treated with Immunotherapy. J Thorac Oncol 2022. [DOI: 10.1016/j.jtho.2022.07.634] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
7
|
Husain M, Xu M, Patel S, Johns A, Grogan M, Li M, Lopez G, Miah A, Hoyd R, Liu Y, Muniak M, Haddad T, Tinoco G, Kendra K, Otterson G, Presley C, Spakowicz D, Owen D. P40.15 Proton Pump Inhibitors, Prior Therapy and Survival in Patients Treated With Immune Checkpoint Inhibitors for Advanced NSCLC. J Thorac Oncol 2021. [DOI: 10.1016/j.jtho.2021.08.452] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
8
|
Corral P, Berg G, Zago V, Lopez G, Bursztyn M, Schreier L. Does remnants-like particle cholesterol is elevated in FH? Atherosclerosis 2021. [DOI: 10.1016/j.atherosclerosis.2021.06.545] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
9
|
Cortazar M, Santamaria L, Lopez G, Alvarez J, Amutio M, Bilbao J, Olazar M. Fe/olivine as primary catalyst in the biomass steam gasification in a fountain confined spouted bed reactor. J IND ENG CHEM 2021. [DOI: 10.1016/j.jiec.2021.04.046] [Citation(s) in RCA: 12] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/20/2023]
|
10
|
Wu MA, Fossali T, Pandolfi L, Carsana L, Ottolina D, Frangipane V, Rech R, Tosoni A, Lopez G, Agarossi A, Cogliati C, Meloni F, Marchini B, Nebuloni M, Catena E, Colombo R. Hypoalbuminemia in COVID-19: assessing the hypothesis for underlying pulmonary capillary leakage. J Intern Med 2021; 289:861-872. [PMID: 33411411 DOI: 10.1111/joim.13208] [Citation(s) in RCA: 31] [Impact Index Per Article: 10.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/14/2020] [Revised: 10/03/2020] [Accepted: 10/22/2020] [Indexed: 02/06/2023]
Abstract
BACKGROUND Since the first observations of patients with COVID-19, significant hypoalbuminaemia was detected. Its causes have not been investigated yet. OBJECTIVE We hypothesized that pulmonary capillary leakage affects the severity of respiratory failure, causing a shift of fluids and proteins through the epithelial-endothelial barrier. METHODS One hundred seventy-four COVID-19 patients with respiratory symptoms, 92 admitted to the intermediate medicine ward (IMW) and 82 to the intensive care unit (ICU) at Luigi Sacco Hospital in Milan, were studied. RESULTS Baseline characteristics at admission were considered. Proteins, interleukin 8 (IL-8) and interleukin 10 (IL-10) in bronchoalveolar lavage fluid (BALF) were analysed in 26 ICU patients. In addition, ten autopsy ultrastructural lung studies were performed in patients with COVID-19 and compared with postmortem findings in a control group (bacterial pneumonia-ARDS and H1N1-ARDS). ICU patients had lower serum albumin than IMW patients [20 (18-23) vs 28 (24-33) g L-1 , P < 0.001]. Serum albumin was lower in more compromised groups (lower PaO2 -to-FiO2 ratio and worst chest X-ray findings) and was associated with 30 days of probability of survival. Protein concentration was correlated with IL-8 and IL-10 levels in BALF. Electron microscopy examinations of eight out of ten COVID-19 lung tissues showed loosening of junctional complexes, quantitatively more pronounced than in controls, and direct viral infection of type 2 pneumocytes and endothelial cells. CONCLUSION Hypoalbuminaemia may serve as severity marker of epithelial-endothelial damage in patients with COVID-19. There are clues that pulmonary capillary leak syndrome plays a key role in the pathogenesis of COVID-19 and might be a potential therapeutic target.
Collapse
Affiliation(s)
- M A Wu
- From the, Division of Internal Medicine, ASST Fatebenefratelli Sacco, Luigi Sacco Hospital, University of Milan, Milan, Italy
| | - T Fossali
- Division of Anesthesiology and Intensive Care, ASST Fatebenefratelli Sacco, Luigi Sacco Hospital, University of Milan, Milan, Italy
| | - L Pandolfi
- Research Laboratory of Lung Diseases, Section of Cell Biology, IRCCS Policlinico San Matteo Foundation, Pavia, Italy
| | - L Carsana
- Pathology Unit, ASST Fatebenefratelli Sacco, Luigi Sacco Hospital, University of Milan, Milan, Italy
| | - D Ottolina
- Division of Anesthesiology and Intensive Care, ASST Fatebenefratelli Sacco, Luigi Sacco Hospital, University of Milan, Milan, Italy
| | - V Frangipane
- Research Laboratory of Lung Diseases, Section of Cell Biology, IRCCS Policlinico San Matteo Foundation, Pavia, Italy
| | - R Rech
- Division of Anesthesiology and Intensive Care, ASST Fatebenefratelli Sacco, Luigi Sacco Hospital, University of Milan, Milan, Italy
| | - A Tosoni
- Pathology Unit, ASST Fatebenefratelli Sacco, Luigi Sacco Hospital, University of Milan, Milan, Italy
| | - G Lopez
- Pathology Unit, ASST Fatebenefratelli Sacco, Luigi Sacco Hospital, University of Milan, Milan, Italy
| | - A Agarossi
- Division of Anesthesiology and Intensive Care, ASST Fatebenefratelli Sacco, Luigi Sacco Hospital, University of Milan, Milan, Italy
| | - C Cogliati
- From the, Division of Internal Medicine, ASST Fatebenefratelli Sacco, Luigi Sacco Hospital, University of Milan, Milan, Italy
| | - F Meloni
- Department of Respiratory Diseases, IRCCS Policlinico San Matteo Foundation, Pavia, Italy.,Department of Internal Medicine, Section of Pneumology, University of Pavia, Pavia, Italy
| | - B Marchini
- Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy
| | - M Nebuloni
- Pathology Unit, ASST Fatebenefratelli Sacco, Luigi Sacco Hospital, University of Milan, Milan, Italy.,Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy
| | - E Catena
- Division of Anesthesiology and Intensive Care, ASST Fatebenefratelli Sacco, Luigi Sacco Hospital, University of Milan, Milan, Italy
| | - R Colombo
- Division of Anesthesiology and Intensive Care, ASST Fatebenefratelli Sacco, Luigi Sacco Hospital, University of Milan, Milan, Italy
| |
Collapse
|
11
|
Surya N, Li M, Zhao S, Wei L, Patel S, Lopez G, Johns A, Grogan M, Bertino E, He K, Shields P, Carbone D, Otterson G, Presley C, Owen D. P75.12 Prognostic Value of Neutrophil to Lymphocyte Ratio in NSCLC Patients Receiving First Line Immune Checkpoint Inhibitor Therapy. J Thorac Oncol 2021. [DOI: 10.1016/j.jtho.2021.01.1046] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
12
|
Sorokowski P, Sorokowska A, Karwowski M, Groyecka A, Aavik T, Akello G, Alm C, Amjad N, Anjum A, Asao K, Atama CS, Atamtürk Duyar D, Ayebare R, Batres C, Bendixen M, Bensafia A, Bizumic B, Boussena M, Buss DM, Butovskaya M, Can S, Cantarero K, Carrier A, Çetinkaya H, Chabin D, Conroy-Beam D, Croy I, Cueto RM, Czub M, Dronova D, Dural S, Duyar I, Ertugrul B, Espinosa A, Estevan I, Esteves CS, Frackowiak T, Graduño JC, Guemaz F, Ha Thu T, Haľamová M, Herak I, Horvat M, Hromatko I, Hui CM, Jaafar JL, Jiang F, Kafetsios K, Kavcic T, Kennair LEO, Kervyn N, Köbis NC, Kostic A, Krasnodębska A, Láng A, Lennard GR, León E, Lindholm T, Lopez G, Alhabahba MM, Mailhos A, Manesi Z, Martinez R, Sainz Martinez M, McKerchar SL, Meskó N, Misra G, Monaghan C, Mora EC, Moya-Garófano A, Musil B, Natividade JC, Nizharadze G, Oberzaucher E, Oleszkiewicz A, Omar Fauzee MS, Onyishi IE, Özener B, Pagani AF, Pakalniskiene V, Parise M, Pawłowski B, Pazhoohi F, Pejičić M, Pisanski A, Pisanski K, Plohl N, Ponciano E, Popa C, Prokop P, Przepiórka A, Quang Lam T, Rizwan M, Różycka-Tran J, Salkičević S, Sargautyte R, Sarmany-Schuller I, Schmehl S, Shahid A, Shaikh R, Sharad S, Simonetti F, Tadinac M, Thi Khanh Ha T, Ugalde González K, Vauclair CM, Vega LD, Widarini DA, Wojciszke B, Yoo G, Zadeh ZF, Zaťková M, Zupančič M, Sternberg RJ. Universality of the Triangular Theory of Love: Adaptation and Psychometric Properties of the Triangular Love Scale in 25 Countries. J Sex Res 2021; 58:106-115. [PMID: 32783568 DOI: 10.1080/00224499.2020.1787318] [Citation(s) in RCA: 13] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/11/2023]
Abstract
The Triangular Theory of Love (measured with Sternberg's Triangular Love Scale - STLS) is a prominent theoretical concept in empirical research on love. To expand the culturally homogeneous body of previous psychometric research regarding the STLS, we conducted a large-scale cross-cultural study with the use of this scale. In total, we examined more than 11,000 respondents, but as a result of applied exclusion criteria, the final analyses were based on a sample of 7332 participants from 25 countries (from all inhabited continents). We tested configural invariance, metric invariance, and scalar invariance, all of which confirmed the cultural universality of the theoretical construct of love analyzed in our study. We also observed that levels of love components differ depending on relationship duration, following the dynamics suggested in the Triangular Theory of Love. Supplementary files with all our data, including results on love intensity across different countries along with STLS versions adapted in a few dozen languages, will further enable more extensive research on the Triangular Theory of Love.
Collapse
Affiliation(s)
- Piotr Sorokowski
- Department of Otorhinolaryngology, TU Dresden, University of Wroclaw and Smell and Taste Clinic
| | - Agnieszka Sorokowska
- Department of Otorhinolaryngology, TU Dresden, University of Wroclaw and Smell and Taste Clinic
| | - Maciej Karwowski
- Department of Otorhinolaryngology, TU Dresden, University of Wroclaw and Smell and Taste Clinic
| | - Agata Groyecka
- Department of Otorhinolaryngology, TU Dresden, University of Wroclaw and Smell and Taste Clinic
| | | | | | | | | | | | | | | | | | | | | | - Mons Bendixen
- Norwegian University of Technology and Science (NTNU)
| | | | | | | | | | - Marina Butovskaya
- Institute of Ethnology and Anthropology, Russian Academy of Sciences
| | - Seda Can
- Department of Psychology, Ankara University
| | | | | | | | | | | | - Ilona Croy
- Technische Universität Dresden Psychotherapy and Psychosomatic Medicine
| | | | - Marcin Czub
- Department of Otorhinolaryngology, TU Dresden, University of Wroclaw and Smell and Taste Clinic
| | - Daria Dronova
- Institute of Ethnology and Anthropology, Russian Academy of Sciences
| | - Seda Dural
- Department of Psychology, Ankara University
| | | | | | | | | | | | - Tomasz Frackowiak
- Department of Otorhinolaryngology, TU Dresden, University of Wroclaw and Smell and Taste Clinic
| | | | | | - Tran Ha Thu
- University of Social Sciences and Humanities, Vietnam National University
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | - Anna Oleszkiewicz
- Department of Otorhinolaryngology, TU Dresden, University of Wroclaw and Smell and Taste Clinic
| | | | | | | | | | | | | | - Bogusław Pawłowski
- Department of Otorhinolaryngology, TU Dresden, University of Wroclaw and Smell and Taste Clinic
| | | | | | | | - Katarzyna Pisanski
- Department of Otorhinolaryngology, TU Dresden, University of Wroclaw and Smell and Taste Clinic
| | | | | | | | - Pavol Prokop
- Comenius University and Slovak Academy of Sciences
| | | | - Truong Quang Lam
- University of Social Sciences and Humanities, Vietnam National University
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | - Bogdan Wojciszke
- University of Social Sciences and Humanities, Vietnam National University
| | | | | | | | | | | |
Collapse
|
13
|
Lopez G, Bennis AC, Barbin Y, Sentchev A, Benoit L, Marié L. Surface currents in the Alderney Race from high-frequency radar measurements and three-dimensional modelling. Philos Trans A Math Phys Eng Sci 2020; 378:20190494. [PMID: 32713313 PMCID: PMC7423030 DOI: 10.1098/rsta.2019.0494] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Accepted: 06/08/2020] [Indexed: 06/11/2023]
Abstract
Two weeks of high-frequency radar measurements collected at the Alderney Race are compared with the results of a three-dimensional fully coupled wave-current model. Spatial current measurements are rare in this site, otherwise well investigated through modelling. Thus, the radar measurements offer a unique opportunity to examine the spatial reliability of numerical results, and can help to improve our understanding of the complex currents in the area. Comparison of observed and modelled surface current velocities showed a good agreement between the methods, represented by root mean squared errors ranging from 14 to 40 cm s-1 and from 18 to 60 cm s-1 during neap and spring tides, respectively. Maximum errors were found in shallow regions with consistently high current velocities, represented by mean neap and spring magnitudes of 1.25 m s-1 and 2.7 m s-1, respectively. Part of the differences between modelled and observed surface currents in these areas are thought to derive from limitations in the k-epsilon turbulence model used to simulate vertical mixing, when the horizontal turbulent transport is high. In addition, radar radial currents showed increased variance over the same regions, and might also be contributing to the discrepancies found. Correlation analyses yielded magnitudes above 0.95 over the entire study area, with better agreement during spring than during neap tides, probably because of an increase in the phase lag between radar and model velocities during the latter. This article is part of the theme issue 'New insights on tidal dynamics and tidal energy harvesting in the Alderney Race'.
Collapse
Affiliation(s)
- G. Lopez
- Morphodynamique Continentale et Côtière (M2C), CNRS UMR 6143, Univ. Caen Normandie, 14000 Caen, France
| | - A.-C. Bennis
- Morphodynamique Continentale et Côtière (M2C), CNRS UMR 6143, Univ. Caen Normandie, 14000 Caen, France
| | - Y. Barbin
- Retired from Institut Méditerranéen d’Oceanologie (MIO), CNRS UMR 7294, IRD, Univ. Toulon, Univ. Aix-Marseille, 83041, Toulon, France
| | - A. Sentchev
- Laboratory of Oceanology and Geosciences, University Littoral Côte d’Opale, Univ. Lille, CNRS UMR 8187 LOG, Wimereux 62930, France
| | - L. Benoit
- Morphodynamique Continentale et Côtière (M2C), CNRS UMR 6143, Univ. Caen Normandie, 14000 Caen, France
| | - L. Marié
- Laboratoire d’Océanographie Physique et Spatiale (LOPS), CNRS UMR 6523, Univ. Brest, Ifremer, IRD, 29280 Plouzané, France
| |
Collapse
|
14
|
Furgerot L, Sentchev A, Bailly du Bois P, Lopez G, Morillon M, Poizot E, Méar Y, Bennis AC. One year of measurements in Alderney Race: preliminary results from database analysis. Philos Trans A Math Phys Eng Sci 2020; 378:20190625. [PMID: 32713311 PMCID: PMC7423026 DOI: 10.1098/rsta.2019.0625] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Accepted: 06/12/2020] [Indexed: 06/11/2023]
Abstract
The Alderney Race is assumed to have the largest tidal-stream energy potential in the north-western European coastal seas. Interaction of the powerful tidal stream with strong wind, high waves and irregular bathymetry creates hydrodynamic conditions of extreme complexity, with high levels of turbulence. A comprehensive dataset has been created to improve the understanding of physical processes, turbulence, tidal stream and resource variability at the site. The database contains a large amount of oceanographic and meteorological measurements acquired in Alderney Race in 2017-2018. This exceptionally long period of observations (nearly one year) became possible due to modern tools and strategies of data acquisition. The paper presents some significant results from the database analysis. Among many results, we would like to underline the following: (i) a wide range of variability of mean flow and sea state parameters was documented; (ii) exceptionally large values of current velocity (7 m s-1) and significant wave height (8 m) were measured during extreme meteorological conditions; (iii) high-frequency variability of current speed during storm events was also found to be very large, with the standard deviation of velocity reaching 0.3 m s-1 in the bottom boundary layer, and 0.6 m s-1 in the surface layer; and (iv) predominant wind and wave direction relative to the flow impacts the wave height and significantly increases the turbulence kinetic energy of the flow. To our knowledge, this is the largest multi-variable database available on potential tidal energy sites. The results of database analysis can represent a significant advance in environmental conditions and resource characterization and provide advanced information to turbine developers. This article is part of the theme issue 'New insights on tidal dynamics and tidal energy harvesting in the Alderney Race'.
Collapse
Affiliation(s)
- L. Furgerot
- LUSAC, Laboratoire Universitaire des Sciences Appliquées de Cherbourg, Univ. Normandie, Cherbourg-en-Cotentin, France
| | - A. Sentchev
- Laboratory of Oceanology and Geosciences, Univ. Littoral Côte d'Opale, Univ. Lille, CNRS UMR 8187, Wimereux 62930, France
| | - P. Bailly du Bois
- Laboratoire de Radioécologie de Cherbourg, IRSN-LRC, Rue Max Pol Fouchet B.P. 10, 50130 Cherbourg en Cotentin, France
| | - G. Lopez
- M2C, Morphodynamique Continentale et Côtière (M2C), Normandie Univ., Caen, France
| | - M. Morillon
- Laboratoire de Radioécologie de Cherbourg, IRSN-LRC, Rue Max Pol Fouchet B.P. 10, 50130 Cherbourg en Cotentin, France
| | - E. Poizot
- Intechmer, Conservatoire National des Arts et Métiers, Cherbourg-en-Cotentin, France
| | - Y. Méar
- Intechmer, Conservatoire National des Arts et Métiers, Cherbourg-en-Cotentin, France
| | - A.-C. Bennis
- M2C, Morphodynamique Continentale et Côtière (M2C), Normandie Univ., Caen, France
| |
Collapse
|
15
|
Fareng M, Lopez G, Fischer L, Morali D. Étude des victimes des attentats du 13 novembre 2015, pris en charge au centre du psychotrauma de l’institut de victimologie. PRAT PSYCHOL 2020. [DOI: 10.1016/j.prps.2019.09.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
16
|
Ienca R, Giardiello C, Scozzarro A, di Cola RS, Di Lorenzo N, Juneja G, Lopez G, Badiuddin F. Improving Nausea and Vomiting Post-Elipse Balloon: a Novel Single-Dose Regimen of 300 mg Netupitant/0.5 mg Palonosetron Hydrochloride. Obes Surg 2020; 29:2952-2956. [PMID: 31104280 DOI: 10.1007/s11695-019-03937-x] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
BACKGROUND Post intragastric balloon placement symptoms like nausea and vomiting have been the major cause of a high rate of early removal. Common therapy with ondansetron alone, or in combination, with prokinetic agents have been shown to have very little or no effect. Recently, an improved therapy based on aprepitant and ondansetron combination showed a significant improvement in symptoms management. Lack of aprepitant availability in several countries and patients difficulties to follow the right prescription convinced us to explore other pharmacological options. OBJECTIVE Evaluate safety and efficacy of a netupitant and palonosetron-combined drug and to reduce and control post Elipse® placement symptoms METHODS: Between January and March 2018, 30 patients (9 male, 21 female), (mean weight 97.8 and mean BMI 34.7), underwent Elispe® placements, at 550 ml volume, in an outpatient fashion. All patients received a single pill 300 mg netupitant/0.5 mg palonosetron 6 h prior to placement. All patients received ondansetron 4 mg prescription to be taken as needed. A daily VAS score to report intensity of nausea, vomit, cramps, gastric pain, satiety for the first week post-placement was completed. RESULTS 4/30 (13%) reported vomiting on days 1, 2, and 3; 9/30 (30%) reported nausea higher than score 4 on days 1, 2, and 3; 8/30 (26.6%) reported gastric pain higher than score 4 on days 1, 2, and 3. CONCLUSION In our experience, the use of a single-pill netupitant/palonosetron resulted to be very easy to administer and effective in reducing vomit, nausea, and gastric pain in 87%, 70%, and 73.4% patients respectively, ameliorating the post Elipse™ placements symptoms safely.
Collapse
Affiliation(s)
- R Ienca
- Elipse Weight Management Center, Nuova Villa Claudia Clinic, Via Flaminia Nuova, 280, Rome, Italia.
| | - C Giardiello
- Emergency and Metabolic Surgery Dept, Pineta Grande Hospital, Via Domitiana Km. 30,00, Caserta, Italy
| | - A Scozzarro
- Department of Surgical Science, Torvergata University, Viale Oxford 81, Rome, Italy
| | - R Schiano di Cola
- Emergency and Metabolic Surgery Dept, Pineta Grande Hospital, Via Domitiana Km. 30,00, Caserta, Italy
| | - N Di Lorenzo
- Department of Surgical Science, Torvergata University, Viale Oxford 81, Rome, Italy
| | - Girish Juneja
- Bariatric Center, Al Zahra Hospital, Al Barsha, Dubai, UAE
| | - G Lopez
- Center for Strategic Healthcare Development, Dubai Science Park, Dubai, UAE
| | - F Badiuddin
- Surgical Division, BR Medical Suites, Healthcare City, Dubai, UAE
| |
Collapse
|
17
|
Paramo L, Garcia E, Meda J, de J. Rubio J, Escobedo J, Tapia R, Hernandez J, Lopez G, Novoa J, Aguilar A. Quadrotor stabilization by Fuzzy Kalman Filter. IFS 2020. [DOI: 10.3233/jifs-191251] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Affiliation(s)
- L.A. Paramo
- SEPI-ESIME Zacatenco, Instituto Politécnico Nacional, Av. IPN, Col. Lindavista, Ciudad de México, México
| | - E.C. Garcia
- SEPI-ESIME Zacatenco, Instituto Politécnico Nacional, Av. IPN, Col. Lindavista, Ciudad de México, México
| | - J.A. Meda
- SEPI-ESIME Zacatenco, Instituto Politécnico Nacional, Av. IPN, Col. Lindavista, Ciudad de México, México
| | - J. de J. Rubio
- SEPI-ESIME Azcapotzalco, Instituto Politécnico Nacional, Av. Las Granjas No. 682, Col. Santa Catarina, Ciudad de México, México
| | - J.O. Escobedo
- SEPI-ESIME Ticomán, Instituto Politécnico Nacional, Av. Ticomán, No. 600, Col. San José Ticomán, Ciudad de México, 07340, México
| | - R. Tapia
- SEPI-ESIME Zacatenco, Instituto Politécnico Nacional, Av. IPN, Col. Lindavista, Ciudad de México, México
| | - J.O. Hernandez
- SEPI-ESIME Zacatenco, Instituto Politécnico Nacional, Av. IPN, Col. Lindavista, Ciudad de México, México
| | - G. Lopez
- SEPI-ESIME Zacatenco, Instituto Politécnico Nacional, Av. IPN, Col. Lindavista, Ciudad de México, México
| | - J.F. Novoa
- SEPI-ESIME Zacatenco, Instituto Politécnico Nacional, Av. IPN, Col. Lindavista, Ciudad de México, México
| | - A. Aguilar
- SEPI-ESIME Zacatenco, Instituto Politécnico Nacional, Av. IPN, Col. Lindavista, Ciudad de México, México
| |
Collapse
|
18
|
Milbury K, Lopez G, Contreras J, Weather SP, Bruera E. Financial Distress and its Associated Burden in Couples Coping with an Incurable Cancer. Cancer Epidemiol Biomarkers Prev 2020. [DOI: 10.1158/1055-9965.epi-20-0072] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Abstract
Abstract
Although financial toxicity has been linked to poor disease outcomes in cancer patients, the associations between subjective financial distress (FD) and symptom burden and quality of life (QOL) are rarely examined from a patient-partner dyadic perspective. Thus, this cross-sectional study seeks to examine dyadic associations in couples coping with an incurable cancer. Method: Patients undergoing systemic and/or radiotherapy for advanced lung cancer (n = 50) or high grade glioma (n = 50) and their spouses/romantic partners completed measures of psychological distress (BSI-18), symptom severity including FD (ESAS, 0–10 scale), QOL (PROMIS-10), relationship wellbeing (SRI), and avoidance (AAQ-2). Results: Patients were mainly female (60%), and patients and partners were all in a heterosexual relationship (mean length: 30.12 ± 15.1 yrs), mainly non-Hispanic White (80%), married to each other (93%) and well educated with a mean age of 57.9 years (range: 28.5–79.0 years). FD was interrelated in couples (ICC = 0.53, P<0.0001), and mean score did not significantly differ by role (patient = 2.32 vs partner = 2.81). Controlling for medical and demographic factors, based on dyadic level analyses, FD was significantly associated with physical QOL (P = 0.01) so that those with higher FD reported lower QOL. Interestingly, FD was significantly associated with psychological distress (P = 0.001), mental QOL (P<0.001), avoidance (P = 0.01), and relationship wellbeing (P = 0.03) for partners but not for patients so that partners reporting higher FD had worse health and wellbeing. Moreover, in terms of relative burden, FD was the 7th (out of 12) most severe symptom for patients, and the 2nd most severe symptom for partners (after sleep disturbances). Based on concordance analyses, patients significantly underestimated their partners' FD (P = 0.007), which was further associated with increased partner psychological distress (P = 0.04). Conclusion: Although FD is interdependent in couples coping with an incurable cancer, FD appears to be a greater relative burden for partners than patients. In the palliative care setting, reducing FD may be an important target for caregiver interventions seeking to improve their health and wellbeing and reduce the overall cancer burden.
Collapse
|
19
|
Liu W, Qdaisat A, Lopez G, Narayanan S, Susan Underwood S, Spano M, Reddy A, Guo Y, Bruera E, Cohen L. Clinical characteristics are associated with acupuncture treatment response for xerostomia in cancer patients. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz265.054] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
20
|
|
21
|
Lopez Ayala P, Rossello X, Fernandez-Jimenez R, Oliver E, Galan C, De Molina-Iracheta A, Aguero J, Lopez G, Lobo-Gonzalez M, Vilchez-Tschischke JP, Fuster V, Sanchez-Gonzalez J, Ibanez B. 23Quantification of post-reperfusion intramyocardial haemorrhage with cardiac magnetic resonance imaging in an ischemia/reperfusion pig model: T2* vs R2* vs R2". Eur Heart J Cardiovasc Imaging 2019. [DOI: 10.1093/ehjci/jez111.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- P Lopez Ayala
- National Centre for Cardiovascular Research (CNIC), Translational Laboratory for Cardiovascular Imaging and Therapy, Madrid, Spain
| | - X Rossello
- National Centre for Cardiovascular Research (CNIC), Translational Laboratory for Cardiovascular Imaging and Therapy, Madrid, Spain
| | - R Fernandez-Jimenez
- National Centre for Cardiovascular Research (CNIC), Translational Laboratory for Cardiovascular Imaging and Therapy, Madrid, Spain
| | - E Oliver
- National Centre for Cardiovascular Research (CNIC), Translational Laboratory for Cardiovascular Imaging and Therapy, Madrid, Spain
| | - C Galan
- National Centre for Cardiovascular Research (CNIC), Translational Laboratory for Cardiovascular Imaging and Therapy, Madrid, Spain
| | - A De Molina-Iracheta
- National Centre for Cardiovascular Research (CNIC), Translational Laboratory for Cardiovascular Imaging and Therapy, Madrid, Spain
| | - J Aguero
- National Centre for Cardiovascular Research (CNIC), Translational Laboratory for Cardiovascular Imaging and Therapy, Madrid, Spain
| | - G Lopez
- National Centre for Cardiovascular Research (CNIC), Translational Laboratory for Cardiovascular Imaging and Therapy, Madrid, Spain
| | - M Lobo-Gonzalez
- National Centre for Cardiovascular Research (CNIC), Translational Laboratory for Cardiovascular Imaging and Therapy, Madrid, Spain
| | - J P Vilchez-Tschischke
- National Centre for Cardiovascular Research (CNIC), Translational Laboratory for Cardiovascular Imaging and Therapy, Madrid, Spain
| | - V Fuster
- The Zena and Michael A. Wiener Cardiovascular Institute, Ican School of Medicine at Mount Sinai, New York, United States of America
| | - J Sanchez-Gonzalez
- National Centre for Cardiovascular Research (CNIC), Translational Laboratory for Cardiovascular Imaging and Therapy, Madrid, Spain
| | - B Ibanez
- National Centre for Cardiovascular Research (CNIC), Translational Laboratory for Cardiovascular Imaging and Therapy, Madrid, Spain
| |
Collapse
|
22
|
Gualpa J, Lopez G, Nievas S, Coniglio A, Halliday N, Cámara M, Cassán F. Azospirillum brasilense Az39, a model rhizobacterium with AHL quorum-quenching capacity. J Appl Microbiol 2019; 126:1850-1860. [PMID: 30924989 DOI: 10.1111/jam.14269] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/30/2018] [Revised: 03/06/2019] [Accepted: 03/24/2019] [Indexed: 12/20/2022]
Abstract
AIMS The aim of this research was to analyse the quorum-sensing (QS) and quorum-quenching (QQ) mechanisms based on N-acyl-l-homoserine lactones (AHLs) in Azospirillum brasilense Az39, a strain with remarkable capacity to benefit a wide range of crops under agronomic conditions. METHODS AND RESULTS We performed an in silico and in vitro analysis of the quorum mechanisms in A. brasilense Az39. The results obtained in vitro using the reporter strains Chromobacterium violaceum and Agrobacterium tumefaciens and liquid chromatography coupled with mass-mass spectrometry analysis showed that although Az39 does not produce AHL molecules, it is capable of degrading them by at least two hypothetical enzymes identified by bioinformatics approach, associated with the bacterial cell. In Az39 cultures supplemented with 500 nmol l-1 of the C3 unsubstituted AHLs (C4, C6, C8, C10, C12, C14), AHL levels were lower than in noninoculated LB media controls. Similar results were observed upon the addition of AHLs with hydroxy (OH-) and keto (oxo-) substitutions in C3. These results not only demonstrate the ability of Az39 to degrade AHLs. They also show the wide spectrum of molecules that can be degraded by this bacterium. CONCLUSIONS Although A. brasilense Az39 is a silent bacterium unable to produce AHL signals, it is able to interrupt the communications between other bacteria and/or plants by a QQ activity. SIGNIFICANCE AND IMPACT OF THE STUDY This is the first report confirming by unequivocal methodology the ability of A. brasilense, one of the most agriculturally used benefic bacteria around the world, to degrade AHLs by a QQ mechanism.
Collapse
Affiliation(s)
- J Gualpa
- Laboratorio de Fisiología Vegetal y de la Interacción Planta-Microorganismo, Universidad Nacional de Río Cuarto, Córdoba, Argentina
| | - G Lopez
- Laboratorio de Fisiología Vegetal y de la Interacción Planta-Microorganismo, Universidad Nacional de Río Cuarto, Córdoba, Argentina
| | - S Nievas
- Laboratorio de Fisiología Vegetal y de la Interacción Planta-Microorganismo, Universidad Nacional de Río Cuarto, Córdoba, Argentina
| | - A Coniglio
- Laboratorio de Fisiología Vegetal y de la Interacción Planta-Microorganismo, Universidad Nacional de Río Cuarto, Córdoba, Argentina
| | - N Halliday
- Centre for Biomolecular Sciences, School of Life Sciences, University of Nottingham, Nottingham, UK
| | - M Cámara
- Centre for Biomolecular Sciences, School of Life Sciences, University of Nottingham, Nottingham, UK
| | - F Cassán
- Laboratorio de Fisiología Vegetal y de la Interacción Planta-Microorganismo, Universidad Nacional de Río Cuarto, Córdoba, Argentina
| |
Collapse
|
23
|
Salas C, Lopez G, Cadiz F, Barriga C, Gonzalez P, Acevedo S, Raimilla P, Pincheira P, Naing A, Quiroga M. Abstract P4-12-04: Use of complementary and integrative medicine therapies in Chilean patients with breast cancer. Experience of a private center: prevalence and characteristics of patients. Cancer Res 2019. [DOI: 10.1158/1538-7445.sabcs18-p4-12-04] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: During the last decade several studies have been reported that the use of complementary and integrative medicine (CIM), defined as health care methods generated outside of standard Western, or conventional clinical practices has been increasing among breast cancer patients in developed countries. However, there is little information about the use of CIM in developing countries. Chile currently has no published statistics on the use of CIM in breast cancer.
Methods: We conducted a cross-sectional survey between March and June 2017 in breast cancer patients treated in Clinica Alemana de Santiago to determine the prevalence of CIM use and the types of preferred CIM. We also analyzed associations between CIM and several variables including sociodemographic variables, the reasons that motivated the use of CIM and the subjective benefits that patients attributed to CIM. Statistical analysis included two tailed t–test for continuous variables, Fischer's exact test for categorical variables and logistic regression for association between CIM use and other variables.
Results: 288 patients answered the survey. Among them, 98.9% were women, mostly between 41 and 50 years (40.4%). 44.9% (n = 129) reported using CIM. No association was found between the use of CIM and sociodemographic variables (sex, age, education, income). Most used CIM types were: vitamins / minerals (50.4%), herbs (48.8%), special diets (42.6%), meditation/prayers (37.2%). The reasons for CIM use were "to do everything possible" (72%), "improve immunity" (67.8%), "reduce side effects of treatment" (32.7%), recommendation by family member or friend (32.7%). Regarding CIM habits, 50.8% of patients reported having started CIM use at the time of diagnosis and only 51.6% reported about CIM use to their attending physician. Most patients reported benefits associated to CAM use (61%) but no differences were found in reported quality of life.
Conclusions: Great amount of the patients reported using CIM and half of them mentioned that they shared this information with their attending physician. It is necessary incorporate to medical routines questions regarding CIM use and to educate the patients regarding the safe use of CIM and the possible interactions of these approaches with conventional clinical practices.
Citation Format: Salas C, Lopez G, Cadiz F, Barriga C, Gonzalez P, Acevedo S, Raimilla P, Pincheira P, Naing A, Quiroga M. Use of complementary and integrative medicine therapies in Chilean patients with breast cancer. Experience of a private center: prevalence and characteristics of patients [abstract]. In: Proceedings of the 2018 San Antonio Breast Cancer Symposium; 2018 Dec 4-8; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2019;79(4 Suppl):Abstract nr P4-12-04.
Collapse
Affiliation(s)
- C Salas
- Clínca Alemana de Santiago, Santiago, Region Metropolitana, Chile; MD Anderson Cancer Center, Houston, TX
| | - G Lopez
- Clínca Alemana de Santiago, Santiago, Region Metropolitana, Chile; MD Anderson Cancer Center, Houston, TX
| | - F Cadiz
- Clínca Alemana de Santiago, Santiago, Region Metropolitana, Chile; MD Anderson Cancer Center, Houston, TX
| | - C Barriga
- Clínca Alemana de Santiago, Santiago, Region Metropolitana, Chile; MD Anderson Cancer Center, Houston, TX
| | - P Gonzalez
- Clínca Alemana de Santiago, Santiago, Region Metropolitana, Chile; MD Anderson Cancer Center, Houston, TX
| | - S Acevedo
- Clínca Alemana de Santiago, Santiago, Region Metropolitana, Chile; MD Anderson Cancer Center, Houston, TX
| | - P Raimilla
- Clínca Alemana de Santiago, Santiago, Region Metropolitana, Chile; MD Anderson Cancer Center, Houston, TX
| | - P Pincheira
- Clínca Alemana de Santiago, Santiago, Region Metropolitana, Chile; MD Anderson Cancer Center, Houston, TX
| | - A Naing
- Clínca Alemana de Santiago, Santiago, Region Metropolitana, Chile; MD Anderson Cancer Center, Houston, TX
| | - M Quiroga
- Clínca Alemana de Santiago, Santiago, Region Metropolitana, Chile; MD Anderson Cancer Center, Houston, TX
| |
Collapse
|
24
|
Fusco N, Corti C, Lopez G, Michelotti A, Despini L, Gambini D, Lorenzini D, Guerini-Rocco E, Maggi S, Noale M, Invernizzi M. Abstract P1-12-09: Proposal for integrating the pathologic assessment of lymphovascular invasion and extranodal tumor extension in breast cancer-related lymphedema clinical management. Cancer Res 2019. [DOI: 10.1158/1538-7445.sabcs18-p1-12-09] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Breast cancer related lymphoedema (BCRL) occurs in a substantial proportion of breast cancer survivors and is a major contributor to disability, representing a long-term threat to these patients. Given the extremely high incidence of breast cancer worldwide, and the increasing number of long-term survivors, the reduction of BCRL burden represents an urgent clinical need in women's healthcare. However, there are no validated predictive biomarkers, diagnostic tools, and strong evidence-supported therapeutic strategies for BCRL management. Here, we provide a comprehensive clinicopathological characterization of a large series of women with node-positive breast cancers and identify new bona fide predictors of BCRL occurrence.
332 cases of surgically-treated node-positive breast cancers were retrospectively collected (2-10.2 years of follow-up). Among them, 62 patients developed BCRL. To identify demographic and clinicopathologic features related to BCRL, Fisher's exact test or Chi-squared test were carried out for categorical variables; the Wilcoxon rank-sum was employed for continuous variables. Factors associated with BCRL occurrence were assessed using a Cox proportional hazards regression model.
En-bloc dissection of the axillary lymph nodes but not the type of breast surgery impacted on BCRL development. Most of BCRL patients had a Luminal A-like neoplasm. The median number of lymph nodes involved by metastatic deposits was significantly higher in BCRL compared to the control group (p=0.04). Both peritumoral lymphovascular invasion (LVI) and extranodal extension (ENE) of the metastasis had a negative impact on BCRL-free survival (p=0.01). Specifically, patients with LVI and left side localization harbored 4-fold higher risk of developing BCRL, while right axillary nodes metastases with ENE increased the probability of BCRL compared to ENE-negative patients.
Here, we document that LVI and ENE have a strong predictive value for BCRL occurrence. Furthermore, we confirm that the full excision of the axillary nodes is one of the major determinants of BCRL, regardless of the extent of the surgical procedure involving the breast. In conclusion, our results suggest that the pathologic data on LVI and ENE should be integrated with information on the laterality of the tumor and the type of surgical procedure. This new integrative approach could be extremely beneficial to improve BCRL risk stratification.
Citation Format: Fusco N, Corti C, Lopez G, Michelotti A, Despini L, Gambini D, Lorenzini D, Guerini-Rocco E, Maggi S, Noale M, Invernizzi M. Proposal for integrating the pathologic assessment of lymphovascular invasion and extranodal tumor extension in breast cancer-related lymphedema clinical management [abstract]. In: Proceedings of the 2018 San Antonio Breast Cancer Symposium; 2018 Dec 4-8; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2019;79(4 Suppl):Abstract nr P1-12-09.
Collapse
Affiliation(s)
- N Fusco
- University of Milan, Milan, MI, Italy; Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, MI, Italy; European Institute of Oncology, Milan, MI, Italy; National Research Council (CNR), Neuroscience Institute Aging Branch,, Padua, PD, Italy; Physical and Rehabilitative Medicine, University of Eastern Piedmont "A. Avogadro", Novara, NO, Italy
| | - C Corti
- University of Milan, Milan, MI, Italy; Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, MI, Italy; European Institute of Oncology, Milan, MI, Italy; National Research Council (CNR), Neuroscience Institute Aging Branch,, Padua, PD, Italy; Physical and Rehabilitative Medicine, University of Eastern Piedmont "A. Avogadro", Novara, NO, Italy
| | - G Lopez
- University of Milan, Milan, MI, Italy; Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, MI, Italy; European Institute of Oncology, Milan, MI, Italy; National Research Council (CNR), Neuroscience Institute Aging Branch,, Padua, PD, Italy; Physical and Rehabilitative Medicine, University of Eastern Piedmont "A. Avogadro", Novara, NO, Italy
| | - A Michelotti
- University of Milan, Milan, MI, Italy; Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, MI, Italy; European Institute of Oncology, Milan, MI, Italy; National Research Council (CNR), Neuroscience Institute Aging Branch,, Padua, PD, Italy; Physical and Rehabilitative Medicine, University of Eastern Piedmont "A. Avogadro", Novara, NO, Italy
| | - L Despini
- University of Milan, Milan, MI, Italy; Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, MI, Italy; European Institute of Oncology, Milan, MI, Italy; National Research Council (CNR), Neuroscience Institute Aging Branch,, Padua, PD, Italy; Physical and Rehabilitative Medicine, University of Eastern Piedmont "A. Avogadro", Novara, NO, Italy
| | - D Gambini
- University of Milan, Milan, MI, Italy; Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, MI, Italy; European Institute of Oncology, Milan, MI, Italy; National Research Council (CNR), Neuroscience Institute Aging Branch,, Padua, PD, Italy; Physical and Rehabilitative Medicine, University of Eastern Piedmont "A. Avogadro", Novara, NO, Italy
| | - D Lorenzini
- University of Milan, Milan, MI, Italy; Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, MI, Italy; European Institute of Oncology, Milan, MI, Italy; National Research Council (CNR), Neuroscience Institute Aging Branch,, Padua, PD, Italy; Physical and Rehabilitative Medicine, University of Eastern Piedmont "A. Avogadro", Novara, NO, Italy
| | - E Guerini-Rocco
- University of Milan, Milan, MI, Italy; Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, MI, Italy; European Institute of Oncology, Milan, MI, Italy; National Research Council (CNR), Neuroscience Institute Aging Branch,, Padua, PD, Italy; Physical and Rehabilitative Medicine, University of Eastern Piedmont "A. Avogadro", Novara, NO, Italy
| | - S Maggi
- University of Milan, Milan, MI, Italy; Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, MI, Italy; European Institute of Oncology, Milan, MI, Italy; National Research Council (CNR), Neuroscience Institute Aging Branch,, Padua, PD, Italy; Physical and Rehabilitative Medicine, University of Eastern Piedmont "A. Avogadro", Novara, NO, Italy
| | - M Noale
- University of Milan, Milan, MI, Italy; Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, MI, Italy; European Institute of Oncology, Milan, MI, Italy; National Research Council (CNR), Neuroscience Institute Aging Branch,, Padua, PD, Italy; Physical and Rehabilitative Medicine, University of Eastern Piedmont "A. Avogadro", Novara, NO, Italy
| | - M Invernizzi
- University of Milan, Milan, MI, Italy; Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, MI, Italy; European Institute of Oncology, Milan, MI, Italy; National Research Council (CNR), Neuroscience Institute Aging Branch,, Padua, PD, Italy; Physical and Rehabilitative Medicine, University of Eastern Piedmont "A. Avogadro", Novara, NO, Italy
| |
Collapse
|
25
|
Fusco N, Lopez G, Corti C, Pesenti C, Colapietro P, Ercoli G, Gaudioso G, Faversani A, Gambini D, Despini L, Blundo C, Vaira V, Miozzo M, Ferrero S, Bosari S. Abstract P2-08-21: Mismatch repair protein loss is a prognostic and predictive biomarker in breast cancers regardless of microsatellite instability. Cancer Res 2019. [DOI: 10.1158/1538-7445.sabcs18-p2-08-21] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Despite the approval of pembrolizumab in all tumors showing mismatch-repair (MMR) deficiency and/or microsatellite instability (MSI), there are currently no companion diagnostics for MMR status assessment in breast cancer. Here, we sought to define the diagnostic and prognostic role of MMR and MSI testing in breast cancer patients.
We subjected 444 breast cancers to MMR immunohistochemistry (IHC) and MSI analysis. Cases were classified as MMR-proficient (pMMR), MMR-deficient (dMMR), and MMR-heterogeneous (hMMR) based on the loss of immunoreactivity; MSI was defined by the instability in the five indicators recommended by the National Cancer Institute for endometrial and colorectal cancers. Correlation of MMR status with patients' survival was assessed using the Kaplan-Meier estimator.
In 75 patients (17%) the loss of MMR proteins was homogeneous, classified as dMMR, while 55 cases (12%) were hMMR. The prevalence of cancers with loss of the MMR proteins was homogeneous across ER+ breast cancers (15-19% for dMMR and 10-18% for hMMR tumors). The level of overlap between IHC and MSI analysis was 9% (p<0.0001). Among ER+/HER2- carcinomas, pMMR and hMMR patients displayed better survival rates (p=0.008). In chemo-treated ER-/HER2- breast cancers, the dMMR status was a marker of good prognosis (p<0.001).
Our study documents the clinical impact of MMR testing in a large series of breast cancers, using the most commonly adopted diagnostic tools and criteria. We show that MMR protein loss is a rather common event in breast cancer and has a remarkable degree of intra-tumor heterogeneity, therefore making the analysis of a small area of the tumor, or a small biopsy, of little clinical value. Our investigation supports the concept that MSI occurs rarely in breast cancer and demonstrate that this condition is restricted to a minority of tumors with MMR protein loss. These data suggest that MMR IHC and MSI analysis should not be considered as interchangeable tests in the diagnostic workup of breast carcinomas. Finally, our observations indicate that the complete loss of at least one of the MMR proteins assessed by IHC is able to identify high-risk ER+/HER2- breast cancers that can potentially benefit from pembrolizumab therapy, whereas first-line chemotherapy shows comparatively good results in dMMR ER-/HER2- breast cancers.
Citation Format: Fusco N, Lopez G, Corti C, Pesenti C, Colapietro P, Ercoli G, Gaudioso G, Faversani A, Gambini D, Despini L, Blundo C, Vaira V, Miozzo M, Ferrero S, Bosari S. Mismatch repair protein loss is a prognostic and predictive biomarker in breast cancers regardless of microsatellite instability [abstract]. In: Proceedings of the 2018 San Antonio Breast Cancer Symposium; 2018 Dec 4-8; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2019;79(4 Suppl):Abstract nr P2-08-21.
Collapse
Affiliation(s)
- N Fusco
- University of Milan, Milan, Italy; Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, Italy; Breast Surgery Unit, Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, Italy
| | - G Lopez
- University of Milan, Milan, Italy; Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, Italy; Breast Surgery Unit, Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, Italy
| | - C Corti
- University of Milan, Milan, Italy; Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, Italy; Breast Surgery Unit, Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, Italy
| | - C Pesenti
- University of Milan, Milan, Italy; Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, Italy; Breast Surgery Unit, Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, Italy
| | - P Colapietro
- University of Milan, Milan, Italy; Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, Italy; Breast Surgery Unit, Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, Italy
| | - G Ercoli
- University of Milan, Milan, Italy; Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, Italy; Breast Surgery Unit, Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, Italy
| | - G Gaudioso
- University of Milan, Milan, Italy; Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, Italy; Breast Surgery Unit, Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, Italy
| | - A Faversani
- University of Milan, Milan, Italy; Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, Italy; Breast Surgery Unit, Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, Italy
| | - D Gambini
- University of Milan, Milan, Italy; Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, Italy; Breast Surgery Unit, Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, Italy
| | - L Despini
- University of Milan, Milan, Italy; Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, Italy; Breast Surgery Unit, Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, Italy
| | - C Blundo
- University of Milan, Milan, Italy; Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, Italy; Breast Surgery Unit, Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, Italy
| | - V Vaira
- University of Milan, Milan, Italy; Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, Italy; Breast Surgery Unit, Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, Italy
| | - M Miozzo
- University of Milan, Milan, Italy; Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, Italy; Breast Surgery Unit, Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, Italy
| | - S Ferrero
- University of Milan, Milan, Italy; Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, Italy; Breast Surgery Unit, Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, Italy
| | - S Bosari
- University of Milan, Milan, Italy; Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, Italy; Breast Surgery Unit, Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, Italy
| |
Collapse
|
26
|
Legostaev VM, Balitsky GV, Lopez G, Islamova EF. [The combined endoscopic treatment of the patient presenting with a large orolaryngopharyngeal papilloma]. Vestn Otorinolaringol 2019; 83:48-50. [PMID: 30721184 DOI: 10.17116/otorino20188306148] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
The present article was designed to illustrate the potential for the combined treatment of a orolaryngopharyngeal papilloma under the conditions of an out-patient setting with the application of the minimally invasive endoscopic surgical intervention, the so-called photodynamic therapy (PDT). The authors describe the clinical case which demonstrate the possibilities for using photodynamic therapy as a component of the combined treatment of papilloma of the hypopharynx including its radical removal. The application of the PDT mdethod in the clinical case reported in the present article was aimed at preventing the recurrence of papillomatosis of the upper respiratory tract. The evaluation of the outcome of the treatment of the patient in the course of the follow-up period is expected to provide the data for the assessment of the clinical effectiveness of the adjuvant PDT technique.
Collapse
Affiliation(s)
- V M Legostaev
- The Endoscopic Department of the Rostov Research Institute of Oncology, Rostov-on-Don, Russian Federation, 344037
| | - G V Balitsky
- The Endoscopic Department of the Rostov Research Institute of Oncology, Rostov-on-Don, Russian Federation, 344037
| | - G Lopez
- The Endoscopic Department of the Rostov Research Institute of Oncology, Rostov-on-Don, Russian Federation, 344037
| | - E F Islamova
- The Endoscopic Department of the Rostov Research Institute of Oncology, Rostov-on-Don, Russian Federation, 344037
| |
Collapse
|
27
|
Comentale G, Palumbo S, Mucerino M, Giordano R, Cioffi S, Russolillo V, Busillo L, Lopez G, Mitrano L, Simeone S, Palma G. RF73 RIGHT VENTRICULAR OUTFLOW TRACT RECONSTRUCTION IN PEDIATRIC CARDIAC SURGERY. J Cardiovasc Med (Hagerstown) 2018. [DOI: 10.2459/01.jcm.0000550025.95602.56] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
|
28
|
Liu W, Qdaisat A, Lopez G, Underwood S, Spano M, Akhila Reddy A, Guo Y, Yeung SC, Bruera E, Garcia M, Cohen L. Acupuncture for peripheral neuropathy in cancer patients: TCM diagnosis as a predictor of treatment response. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy300.012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
29
|
Rivera D, Mora V, Lopez G, Rosas S, Spaepen S, Vanderleyden J, Cassan F. New insights into indole-3-acetic acid metabolism in Azospirillum brasilense. J Appl Microbiol 2018; 125:1774-1785. [PMID: 30144254 DOI: 10.1111/jam.14080] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/02/2018] [Revised: 08/16/2018] [Accepted: 08/18/2018] [Indexed: 11/30/2022]
Abstract
AIMS The aim of this research was to analyse the global indole-3-acetic acid (IAA) metabolism in three commercially used strains of Azospirillum brasilense. METHODS AND RESULTS Azospirillum brasilense Sp245, Az39 and Cd, containing a plasmid with the ipdC-gusA fusion (pFAJ64), were cultured in minimal medium MMAB with or without 10 mg l-1 of l-trp till exponential or stationary growth phase. The cultures were then split into 10 ml tubes and individually treated with 10 mg ml-1 IAA, IBA or NAA (auxin catabolism and homeostasis); IAPhe, IALeu, IAA-ala, IAA-glucose (IAA conjugate hydrolysis); or l-lys, l-leu, l-ileu, l-phe, l-ala, l-val, l-arg, l-glu, l-his, l-met, l-asp, l-cys, l-ser, l-pro, l-thr and l-trp (regulation of IAA biosynthesis and IAA conjugation). Bacterial growth, IAA production and ipdC expression were evaluated. None of the A. brasilense strains were able to hydrolyse IAA conjugates, catabolize auxins, or conjugate IAA with amino acids or glucose. l-amino acids l-met, l-val, l-cys and l-ser inhibited bacterial growth and decreased IAA biosynthesis. The expression of ipdC and IAA biosynthesis but not bacterial growth was affected by l-leu, l-phe, l-ala, l-ile, l-pro. l-arg, l-glu, l-his, l-lys, l-asp and l-thr did not affect any of the measured parameters. CONCLUSIONS In this paper, we confirmed that A. brasilense produces IAA only in presence of l-trp is not able to degrade auxins, conjugate IAA with sugars and/or l-amino acids, or hydrolyse such conjugates to release free IAA. Finally, we found that bacterial growth and/or IAA biosynthesis were inhibited by the presence of several l-amino acids probably by diversion of the cellular metabolism. SIGNIFICANCE AND IMPACT OF THE STUDY We propose a renewed model to explain IAA metabolism in A. brasilense, one of the most studied phytostimulatory bacteria.
Collapse
Affiliation(s)
- D Rivera
- Universidad Nacional de Río Cuarto, Río Cuarto, Córdoba, Argentina
| | - V Mora
- Universidad Nacional de Río Cuarto, Río Cuarto, Córdoba, Argentina
| | - G Lopez
- Universidad Nacional de Río Cuarto, Río Cuarto, Córdoba, Argentina
| | - S Rosas
- Universidad Nacional de Río Cuarto, Río Cuarto, Córdoba, Argentina
| | - S Spaepen
- Katholieke Universiteit Leuven, Leuven, Belgium
| | | | - F Cassan
- Universidad Nacional de Río Cuarto, Río Cuarto, Córdoba, Argentina
| |
Collapse
|
30
|
Duran MV, Lopez G, Penco S. Yield of blood culture by lysis- centrifugation method in disseminated histoplasmosis in HIV patients. Int J Infect Dis 2018. [DOI: 10.1016/j.ijid.2018.04.4047] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
31
|
Goldfarb I, Lopez G, Naqvi M, Riley L. ZIKV exposed pregnant women: testing utilization and pregnancy outcomes. Am J Obstet Gynecol 2017. [DOI: 10.1016/j.ajog.2017.08.072] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
32
|
Von Seth M, Hillered L, Otterbeck A, Hanslin K, Larsson A, Sjölin J, Lipcsey M, Cove ME, Chew NS, Vu LH, Lim RZ, Puthucheary Z, Hanslin K, Wilske F, Skorup P, Tano E, Sjölin J, Lipcsey M, Derese I, Thiessen S, Derde S, Dufour T, Pauwels L, Bekhuis Y, Van den Berghe G, Vanhorebeek I, Khan M, Dwivedi D, Zhou J, Prat A, Seidah NG, Liaw PC, Fox-Robichaud AE, Von Seth M, Skorup P, Hillered L, Larsson A, Sjölin J, Lipcsey M, Otterbeck A, Hanslin K, Lipcsey M, Larsson A, Von Seth M, Correa T, Pereira J, Takala J, Jakob S, Skorup P, Maudsdotter L, Tano E, Lipcsey M, Castegren M, Larsson A, Sjölin J, Xue M, Xu JY, Liu L, Huang YZ, Guo FM, Yang Y, Qiu HB, Kuzovlev A, Moroz V, Goloubev A, Myazin A, Chumachenko A, Pisarev V, Takeyama N, Tsuda M, Kanou H, Aoki R, Kajita Y, Hashiba M, Terashima T, Tomino A, Davies R, O’Dea KP, Soni S, Ward JK, O’Callaghan DJ, Takata M, Gordon AC, Wilson J, Zhao Y, Singer M, Spencer J, Shankar-Hari M, Genga KR, Lo C, Cirstea MS, Walley KR, Russell JA, Linder A, Boyd JH, Sedlag A, Riedel C, Georgieff M, Barth E, Debain A, Jonckheer J, Moeyersons W, Van zwam K, Puis L, Staessens K, Honoré PM, Spapen HD, De Waele E, de Garibay APR, Bracht H, Ende-Schneider B, Schreiber C, Kreymann B, Bini A, Votino E, Giuliano G, Steinberg I, Vetrugno L, Trunfio D, Sidoti A, Essig A, Brogi E, Forfori F, Conroy M, Marsh B, O’Flynn J, Henne-Bruns D, Gebhard F, Orend K, Halatsch M, Weiss M, Chase M, Freinkman E, Uber A, Liu X, Cocchi MN, Donnino MW, Peetermans M, Liesenborghs L, Claes J, Vanassche T, Hoylaerts M, Jacquemin M, Vanhoorelbeke K, De Meyer S, Verhamme P, Vögeli A, Ottiger M, Meier M, Steuer C, Bernasconi L, Huber A, Christ-Crain M, Henzen C, Hoess C, Thomann R, Zimmerli W, Müller B, Schütz P, Hoppensteadt D, Walborn A, Rondina M, Tsuruta K, Fareed J, Tachyla S, Ikeda T, Ono S, Ueno T, Suda S, Nagura T, Damiani E, Domizi R, Scorcella C, Tondi S, Pierantozzi S, Ciucani S, Mininno N, Adrario E, Pelaia P, Donati A, Andersen MS, Lu S, Lopez G, Lassen AT, Ghiran I, Shapiro NI, Trahtemberg U, Sviri S, Beil M, Agur Z, Van Heerden P, Jahaj E, Vassiliou A, Mastora Z, Orfanos SE, Kotanidou A, Wirz Y, Sager R, Amin D, Amin A, Haubitz S, Hausfater P, Huber A, Kutz A, Mueller B, Schuetz P, Sager RS, Wirz YW, Amin DA, Amin AA, Hausfater PH, Huber AH, Haubitz S, Kutz A, Mueller B, Schuetz P, Gottin L, Dell’amore C, Stringari G, Cogo G, Ceolagraziadei M, Sommavilla M, Soldani F, Polati E, Meier M, Baumgartner T, Zurauskaité G, Gupta S, Mueller B, Devendra A, Schuetz P, Mandaci D, Eren G, Ozturk F, Emir N, Hergunsel O, Azaiez S, Khedher S, Maaoui A, Salem M, Chernevskaya E, Beloborodova N, Bedova A, Sarshor YU, Pautova A, Gusarov V, Öveges N, László I, Forgács M, Kiss T, Hankovszky P, Palágyi P, Bebes A, Gubán B, Földesi I, Araczki Á, Telkes M, Ondrik Z, Helyes Z, Kemény Á, Molnár Z, Spanuth E, Ebelt H, Ivandic B, Thomae R, Werdan K, El-Shafie M, Taema K, El-Hallag M, Kandeel A, Tayeh O, Taema K, Eldesouky M, Omara A, Winkler MS, Holzmann M, Nierhaus A, Mudersbach E, Schwedhelm E, Daum G, Kluge S, Zoellner C, Greiwe G, Sawari H, Schwedhelm E, Nierhaus A, Kluge S, Kubitz J, Jung R, Daum G, Reichenspurner H, Zoellner C, Winkler MS, Groznik M, Ihan A, Andersen LW, Chase M, Holmberg MJ, Wulff A, Cocchi MN, Donnino MW, Balci C, Haliloglu M, Bilgili B, Bilgin H, Kasapoglu U, Sayan I, Süzer M, Mulazımoglu L, Cinel I, Patel V, Shah S, Parulekar P, Minton C, Patel J, Ejimofo C, Choi H, Costa R, Caruso P, Nassar P, Fu J, Jin J, Xu Y, Kong J, Wu D, Yaguchi A, Klonis A, Ganguly S, Kollef M, Burnham C, Fuller B, Mavrommati A, Chatzilia D, Salla E, Papadaki E, Kamariotis S, Christodoulatos S, Stylianakis A, Alamanos G, Simoes M, Trigo E, Silva N, Martins P, Pimentel J, Baily D, Curran LA, Ahmadnia E, Patel BV, Adukauskiene D, Cyziute J, Adukauskaite A, Pentiokiniene D, Righetti F, Colombaroli E, Castellano G, Wilske F, Skorup P, Lipcsey M, Hanslin K, Larsson A, Sjölin J, Man M, Shum HP, Chan YH, Chan KC, Yan WW, Lee RA, Lau SK, Dilokpattanamongkol P, Thirapakpoomanunt P, Anakkamaetee R, Montakantikul P, Tangsujaritvijit V, Sinha S, Pati J, Sahu S, Adukauskiene D, Valanciene D, Dambrauskiene A, Adukauskiene D, Valanciene D, Dambrauskiene A, Hernandez K, Lopez T, Saca D, Bello M, Mahmood W, Hamed K, Al Badi N, AlThawadi S, Al Hosaini S, Salahuddin N, Cilloniz CC, Ceccato AC, Bassi GLL, Ferrer MF, Gabarrus AG, Ranzani OR, Jose ASS, Vidal CGG, de la Bella Casa JPP, Blasi FB, Torres AT, Adukauskiene D, Ciginskiene A, Dambrauskiene A, Simoliuniene R, Giuliano G, Triunfio D, Sozio E, Taddei E, Brogi E, Sbrana F, Ripoli A, Bertolino G, Tascini C, Forfori F, Fleischmann C, Goldfarb D, Schlattmann P, Schlapbach L, Kissoon N, Baykara N, Akalin H, Arslantas MK, Gavrilovic SG, Vukoja MV, Hache MH, Kashyap RK, Dong YD, Gajic OG, Ranzani O, Shankar-Hari M, Harrison D, Rabello L, Rowan K, Salluh J, Soares M, Markota AM, Fluher JF, Kogler DK, Borovšak ZB, Sinkovic AS, László I, Öveges N, Forgács M, Kiss T, Hankovszky P, Palágyi P, Bebes A, Gubán B, Földesi I, Araczki Á, Telkes M, Ondrik Z, Helyes Z, Kemény Á, Molnár Z, Fareed J, Siddiqui Z, Aggarwal P, Iqbal O, Hoppensteadt D, Lewis M, Wasmund R, Abro S, Raghuvir S, Tsuruta K, Barie PS, Fineberg D, Radford A, Tsuruta K, Casazza A, Vilardo A, Bellazzi E, Boschi R, Ciprandi D, Gigliuto C, Preda R, Vanzino R, Vetere M, Carnevale L, Kyriazopoulou E, Pistiki A, Routsi C, Tsangaris I, Giamarellos-Bourboulis E, Kyriazopoulou E, Tsangaris I, Routsi C, Pnevmatikos I, Vlachogiannis G, Antoniadou E, Mandragos K, Armaganidis A, Giamarellos-Bourboulis E, Allan P, Oehmen R, Luo J, Ellis C, Latham P, Newman J, Pritchett C, Pandya D, Cripps A, Harris S, Jadav M, Langford R, Ko B, Park H, Beumer CM, Koch R, Beuningen DV, Oudelashof AM, Vd Veerdonk FL, Kolwijck E, VanderHoeven JG, Bergmans DC, Hoedemaekers C, Brandt JB, Golej J, Burda G, Mostafa G, Schneider A, Vargha R, Hermon M, Levin P, Broyer C, Assous M, Wiener-Well Y, Dahan M, Benenson S, Ben-Chetrit E, Faux A, Sherazi R, Sethi A, Saha S, Kiselevskiy M, Gromova E, Loginov S, Tchikileva I, Dolzhikova Y, Krotenko N, Vlasenko R, Anisimova N, Spadaro S, Fogagnolo A, Remelli F, Alvisi V, Romanello A, Marangoni E, Volta C, Degrassi A, Mearelli F, Casarsa C, Fiotti N, Biolo G, Cariqueo M, Luengo C, Galvez R, Romero C, Cornejo R, Llanos O, Estuardo N, Alarcon P, Magazi B, Khan S, Pasipanodya J, Eriksson M, Strandberg G, Lipsey M, Larsson A, Rajput Z, Hiscock F, Karadag T, Uwagwu J, Jain S, Molokhia A, Barrasa H, Soraluce A, Uson E, Rodriguez A, Isla A, Martin A, Fernández B, Fonseca F, Sánchez-Izquierdo JA, Maynar FJ, Kaffarnik M, Alraish R, Frey O, Roehr A, Stockmann M, Wicha S, Shortridge D, Castanheira M, Sader HS, Streit JM, Flamm RK, Falsetta K, Lam T, Reidt S, Jancik J, Kinoshita T, Yoshimura J, Yamakawa K, Fujimi S, Armaganidis A, Torres A, Zakynthinos S, Mandragos C, Giamarellos-Bourboulis E, Ramirez P, De la Torre-Prados M, Rodriguez A, Dale G, Wach A, Beni L, Hooftman L, Zwingelstein C, François B, Colin G, Dequin PF, Laterre PF, Perez A, Welte R, Lorenz I, Eller P, Joannidis M, Bellmann R, Lim S, Chana S, Patel S, Higuera J, Cabestrero D, Rey L, Narváez G, Blandino A, Aroca M, Saéz S, De Pablo R, Thiessen S, Vanhorebeek I, Derde S, Derese I, Dufour T, Albert CN, Langouche L, Goossens C, Peersman N, Vermeersch P, Vander Perre S, Holst J, Wouters P, Van den Berghe G, Liu X, Uber AU, Holmberg M, Konanki V, McNaughton M, Zhang J, Donnino MW, Demirkiran O, Byelyalov A, Luengo C, Guerrero J, Cariqueo M, Scorcella C, Domizi R, Damiani E, Tondi S, Pierantozzi S, Rossini N, Falanga U, Monaldi V, Adrario E, Pelaia P, Donati A, Cole O, Scawn N, Balciunas M, Blascovics I, Vuylsteke A, Salaunkey K, Omar A, Salama A, Allam M, Alkhulaifi A, Verstraete S, Vanhorebeek I, Van Puffelen E, Derese I, Ingels C, Verbruggen S, Wouters P, Joosten K, Hanot J, Guerra G, Vlasselaers D, Lin J, Van den Berghe G, Haines R, Zolfaghari P, Hewson R, Offiah C, Prowle J, Park H, Ko B, Buter H, Veenstra JA, Koopmans M, Boerma EC, Veenstra JA, Buter H, Koopmans M, Boerma EC, Taha A, Shafie A, Hallaj S, Gharaibeh D, Hon H, Bizrane M, El Khattate AA, Madani N, Abouqal R, Belayachi J, Kongpolprom N, Sanguanwong N, Sanaie S, Mahmoodpoor A, Hamishehkar H, Biderman P, Van Heerden P, Avitzur Y, Solomon S, Iakobishvili Z, Carmi U, Gorfil D, Singer P, Paisley C, Patrick-Heselton J, Mogk M, Humphreys J, Welters I, Pierantozzi S, Scorcella C, Domizi R, Damiani E, Tondi S, Casarotta E, Bolognini S, Adrario E, Pelaia P, Donati A, Holmberg MJ, Moskowitz A, Patel P, Grossestreuer A, Uber A, Andersen LW, Donnino MW, Malinverni S, Goedeme D, Mols P, Langlois PL, Szwec C, D’Aragon F, Heyland DK, Manzanares W, Manzanares W, Szwec C, Langlois P, Aramendi I, Heyland D, Stankovic N, Nadler J, Uber A, Holmberg M, Sanchez L, Wolfe R, Chase M, Donnino M, Cocchi M, Atalan HK, Gucyetmez B, Kavlak ME, Aslan S, Kargi A, Yazici S, Donmez R, Polat KY, Piechota M, Piechota A, Misztal M, Bernas S, Pietraszek-Grzywaczewska I, Saleh M, Hamdy A, Hamdy A, Elhallag M, Atar F, Kundakci A, Gedik E, Sahinturk H, Zeyneloglu P, Pirat A, Popescu M, Tomescu D, Van Gassel R, Baggerman M, Schaap F, Bol M, Nicolaes G, Beurskens D, Damink SO, Van de Poll M, Horibe M, Sasaki M, Sanui M, Iwasaki E, Sawano H, Goto T, Ikeura T, Hamada T, Oda T, Mayumi T, Kanai T, Kjøsen G, Horneland R, Rydenfelt K, Aandahl E, Tønnessen T, Haugaa H, Lockett P, Evans L, Somerset L, Ker-Reid F, Laver S, Courtney E, Dalton S, Georgiou A, Robinson K, Lam T, Haas B, Reidt S, Bartlett K, Jancik J, Bigwood M, Hanley R, Morgan P, Marouli D, Chatzimichali A, Kolyvaki S, Panteli A, Diamantaki E, Pediaditis E, Sirogianni P, Ginos P, Kondili E, Georgopoulos D, Askitopoulou H, Zampieri FG, Liborio AB, Besen BA, Cavalcanti AB, Dominedò C, Dell’Anna AM, Monayer A, Grieco DL, Barelli R, Cutuli SL, Maddalena AI, Picconi E, Sonnino C, Sandroni C, Antonelli M, Gucyetmez B, Atalan HK, Tuzuner F, Cakar N, Jacob M, Sahu S, Singh YP, Mehta Y, Yang KY, Kuo S, Rai V, Cheng T, Ertmer C, Czempik P, Hutchings S, Watts S, Wilson C, Burton C, Kirkman E, Drennan D, O’Prey A, MacKay A, Forrest R, Oglinda A, Ciobanu G, Casian M, Oglinda C, Lun CT, Yuen HJ, Ng G, Leung A, So SO, Chan HS, Lai KY, Sanguanwit P, Charoensuk W, Phakdeekitcharoen B, Batres-Baires G, Kammerzell I, Lahmer T, Mayr U, Schmid R, Huber W, Spanuth E, Bomberg H, Klingele M, Thomae R, Groesdonk H, Bernas S, Piechota M, Mirkiewicz K, Pérez AG, Silva J, Ramos A, Acharta F, Perezlindo M, Lovesio L, Antonelli PG, Dogliotti A, Lovesio C, Baron J, Schiefer J, Baron DM, Faybik P, Shum HP, Yan WW, Chan TM, Marouli D, Chatzimichali A, Kolyvaki S, Panteli A, Diamantaki E, Pediaditis E, Sirogianni P, Ginos P, Kondili E, Georgopoulos D, Askitopoulou H, Vicka V, Gineityte D, Ringaitiene D, Sipylaite J, Pekarskiene J, Beurskens DM, Van Smaalen TC, Hoogland P, Winkens B, Christiaans MH, Reutelingsperger CP, Van Heurn E, Nicolaes GA, Schmitt FS, Salgado ES, Friebe JF, Fleming TF, Zemva JZ, Schmoch TS, Uhle FU, Kihm LK, Morath CM, Nusshag CN, Zeier MZ, Bruckner TB, Mehrabi AM, Nawroth PN, Weigand MW, Hofer SH, Brenner TB, Fotopoulou G, Poularas I, Kokkoris S, Brountzos E, Zakynthinos S, Routsi C, Saleh M, Elghonemi M, Nilsson KF, Sandin J, Gustafsson L, Frithiof R, Skorniakov I, Varaksin A, Vikulova D, Shaikh O, Whiteley C, Ostermann M, Di Lascio G, Anicetti L, Bonizzoli M, Fulceri G, Migliaccio ML, Sentina P, Cozzolino M, Peris A, Khadzhynov D, Halleck F, Staeck O, Lehner L, Budde K, Slowinski T, Slowinski T, Kindgen-Milles D, Khadzhynov D, Huysmans N, Laenen MV, Helmschrodt A, Boer W. 37th International Symposium on Intensive Care and Emergency Medicine (part 3 of 3). Crit Care 2017. [PMCID: PMC5374592 DOI: 10.1186/s13054-017-1629-x] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
|
33
|
Fusco N, Gambini D, Runza L, Lopez G, Ercoli G, Despini L, Bosari S. Abstract P5-06-07: PTEN immunohistochemistry is a predictor of mismatch repair status in breast cancer. Cancer Res 2017. [DOI: 10.1158/1538-7445.sabcs16-p5-06-07] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Phosphatase and tensin homolog (PTEN), a potent downregulator of the PI3K-Akt pathway, has been shown to mediate the interaction between poly (ADP-ribose) polymerases (PARPs) and the mismatch repair (MMR) complex in endometrial and ovarian cancer. Drugs inhibiting PARPs (iPARPs) are currently considered promising therapeutic tools in a subset of PTEN-defective tumors. Regrettably, the frequency and significance of MMR alterations in breast cancer is debated, and their relationship with PTEN status has not been investigated in the breast. Furthermore, many of the studies on the DNA damage response and its therapeutic implications in breast cancer focus on inherited syndromes (e.g. Lynch syndrome and hereditary breast-ovarian cancer syndrome).
Aims: We sought to explore the interplay between PTEN and the MMR system and to define whether PTEN immunohistochemistry (IHC) is a predictor of MMR proficiency in non-familial breast cancers.
Methods: 373 cases of non-familial breast cancers, including a representative number of no special (n=295) and special types (n=78), carefully characterized from clinical and pathological standpoints, were reviewed and used to construct 14 tissue microarrays (TMAs). For each case, a mean of 4.5 tumor tissue cores (range 3 to 6 cores) was sampled, incorporating distinct topographic areas of the tumor, as well as matched non-neoplastic breast tissue. Taken together, 1876 spots were generated. Each TMA was subjected to IHC for PTEN and the DNA MMR proteins MLH1, MSH2, MSH6 and PMS2. In order to minimize human-related biases, each stained slide was digitalized and two pathologists blindly analyzed each tumor spot using a dedicated software able to segment and randomize TMA cores. The pattern of expression was therefore annotated manually on a digital database using a specific add-on module to reconstruct the original topography.
Results: According to clinicopathologic surrogate definition of intrinsic subtypes, PTEN protein loss or heterogeneous expression was more frequent in estrogen receptor negative cancers. Furthermore, 100% of the MMR-proficient luminal B-like (HER2+) and triple-negative breast cancers displayed strong and diffuse homogeneous PTEN expression, while PTEN-positive status identified MMR-proficient luminal A-like and luminal B (HER2-) like tumors with accuracy rates of 89.3% and 92.7%, respectively (p=0.001, Fisher's exact test).
Conclusions: The present study is the first to investigate PTEN protein loss in a large set of non-familial breast carcinomas based on their DNA MMR status by IHC. Here, we demonstrated that PTEN strong and homogeneous expression by IHC is able to capture the vast majority of MMR-proficient non-familial breast cancers. Our findings broaden the understanding of the biology underpinning these tumors, suggesting that PTEN is likely play a role in the development of MMR alterations. Given that PTEN-defective breast cancers have the propensity to develop additional somatic alterations in the MMR system, our results suggest that IHC for PTEN and MMR proteins may be emplyed as an ancillary study to define new subclasses of sporadic breast cancers potentially eligible for iPARPs therapies.
Citation Format: Fusco N, Gambini D, Runza L, Lopez G, Ercoli G, Despini L, Bosari S. PTEN immunohistochemistry is a predictor of mismatch repair status in breast cancer [abstract]. In: Proceedings of the 2016 San Antonio Breast Cancer Symposium; 2016 Dec 6-10; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2017;77(4 Suppl):Abstract nr P5-06-07.
Collapse
Affiliation(s)
- N Fusco
- Fondazione IRCSS Ca' Granda - Ospedale Maggiore Policlinico, Milan, Italy; University of Milan, Milan, Italy; Breast Surgery Unit, Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, Italy
| | - D Gambini
- Fondazione IRCSS Ca' Granda - Ospedale Maggiore Policlinico, Milan, Italy; University of Milan, Milan, Italy; Breast Surgery Unit, Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, Italy
| | - L Runza
- Fondazione IRCSS Ca' Granda - Ospedale Maggiore Policlinico, Milan, Italy; University of Milan, Milan, Italy; Breast Surgery Unit, Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, Italy
| | - G Lopez
- Fondazione IRCSS Ca' Granda - Ospedale Maggiore Policlinico, Milan, Italy; University of Milan, Milan, Italy; Breast Surgery Unit, Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, Italy
| | - G Ercoli
- Fondazione IRCSS Ca' Granda - Ospedale Maggiore Policlinico, Milan, Italy; University of Milan, Milan, Italy; Breast Surgery Unit, Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, Italy
| | - L Despini
- Fondazione IRCSS Ca' Granda - Ospedale Maggiore Policlinico, Milan, Italy; University of Milan, Milan, Italy; Breast Surgery Unit, Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, Italy
| | - S Bosari
- Fondazione IRCSS Ca' Granda - Ospedale Maggiore Policlinico, Milan, Italy; University of Milan, Milan, Italy; Breast Surgery Unit, Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, Italy
| |
Collapse
|
34
|
Zewdu A, Lopez G, Braggio D, Kenny C, Constantino D, Bid HK, Batte K, Iwenofu OH, Oberlies NH, Pearce CJ, Strohecker AM, Lev D, Pollock RE. Verticillin A Inhibits Leiomyosarcoma and Malignant Peripheral Nerve Sheath Tumor Growth via Induction of Apoptosis. ACTA ACUST UNITED AC 2016; 6. [PMID: 28184331 PMCID: PMC5295762 DOI: 10.4172/2161-1459.1000221] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/17/2022]
Abstract
Objective The heterogeneity of soft tissue sarcoma (STS) represents a major challenge for the development of effective therapeutics. Comprised of over 50 different histology subtypes of various etiologies, STS subsets are further characterized as either karyotypically simple or complex. Due to the number of genetic anomalies associated with genetically complex STS, development of therapies demonstrating potency against this STS cluster is especially challenging and yet greatly needed. Verticillin A is a small molecule natural product with demonstrated anticancer activity; however, the efficacy of this agent has never been evaluated in STS. Therefore, the goal of this study was to explore verticillin A as a potential STS therapeutic. Methods We performed survival (MTS) and clonogenic analyses to measure the impact of this agent on the viability and colony formation capability of karyotypically complex STS cell lines: malignant peripheral nerve sheath tumor (MPNST) and leiomyosarcoma (LMS). The in vitro effects of verticillin A on apoptosis were investigated through annexin V/PI flow cytometry analysis and by measuring fluorescently-labeled cleaved caspase 3/7 activity. The impact on cell cycle progression was assessed via cytometric measurement of propidium iodide intercalation. In vivo studies were performed using MPNST xenograft models. Tumors were processed and analyzed using immunohistochemistry (IHC) for verticillin A effects on growth (Ki67) and apoptosis (cleaved caspase 3). Results Treatment with verticillin A resulted in decreased STS growth and an increase in apoptotic levels after 24 h. 100 nM verticillin A induced significant cellular growth abrogation after 24 h (96.7, 88.7, 72.7, 57, and 39.7% reduction in LMS1, S462, ST88, SKLMS1, and MPNST724, respectively). We observed no arrest in cell cycle, elevated annexin, and a nearly two-fold increase in cleaved caspase 3/7 activity in all MPNST and LMS cell lines. Control normal human Schwann (HSC) and aortic smooth muscle (HASMC) cells displayed higher tolerance to verticillin A treatment compared to sarcoma cell lines, although toxicity was seen in HSC at the highest treatment dose. In vivo studies mirrored the in vitro results: by day 11, tumor size was significantly reduced in MPNST724 xenograft models with treatment of 0.25 and 0.5 mg/kg verticillin A. Additionally, IHC assessment of tumors demonstrated increased cleaved caspase 3 and decreased proliferation (Ki67) following treatment with verticillin A. Conclusion Advancement in the treatment of karyotypically complex STS is confounded by the high level of genetic abnormalities found in these diseases. Consequently, the identification and investigation of novel therapies is greatly needed. Our data suggest that verticillin A selectively inhibits MPNST and LMS growth via induction of apoptosis while exhibiting minimal to moderate effects on normal cells, pointing to verticillin A as a potential treatment for MPNST and LMS, after additional preclinical validation.
Collapse
Affiliation(s)
- A Zewdu
- Department of Surgical Oncology, Ohio State University Wexner Medical Center, Columbus, Ohio, USA; The James Cancer Center, Ohio State University Wexner Medical Center, Columbus, Ohio, USA
| | - G Lopez
- Department of Surgical Oncology, Ohio State University Wexner Medical Center, Columbus, Ohio, USA; The James Cancer Center, Ohio State University Wexner Medical Center, Columbus, Ohio, USA
| | - D Braggio
- Department of Surgical Oncology, Ohio State University Wexner Medical Center, Columbus, Ohio, USA; The James Cancer Center, Ohio State University Wexner Medical Center, Columbus, Ohio, USA
| | - C Kenny
- Department of Surgical Oncology, Ohio State University Wexner Medical Center, Columbus, Ohio, USA; The James Cancer Center, Ohio State University Wexner Medical Center, Columbus, Ohio, USA
| | - D Constantino
- Department of Surgical Oncology, Ohio State University Wexner Medical Center, Columbus, Ohio, USA; The James Cancer Center, Ohio State University Wexner Medical Center, Columbus, Ohio, USA
| | - H K Bid
- Department of Surgical Oncology, Ohio State University Wexner Medical Center, Columbus, Ohio, USA; The James Cancer Center, Ohio State University Wexner Medical Center, Columbus, Ohio, USA; Resonant Therapeutics, Inc., Ann Arbor, Michigan, USA
| | - K Batte
- Department of Surgical Oncology, Ohio State University Wexner Medical Center, Columbus, Ohio, USA; The James Cancer Center, Ohio State University Wexner Medical Center, Columbus, Ohio, USA
| | - O H Iwenofu
- Department of Surgical Oncology, Ohio State University Wexner Medical Center, Columbus, Ohio, USA; The James Cancer Center, Ohio State University Wexner Medical Center, Columbus, Ohio, USA; Department of Pathology, Comprehensive Cancer Center, Ohio State University, Columbus, Ohio, USA
| | - N H Oberlies
- Department of Chemistry and Biochemistry, University of North Carolina at Greensboro, Greensboro, North Carolina, USA
| | - C J Pearce
- Mycosynthetix, Inc., Hillsborough, North Carolina, USA
| | - A M Strohecker
- Department of Surgical Oncology, Ohio State University Wexner Medical Center, Columbus, Ohio, USA; The James Cancer Center, Ohio State University Wexner Medical Center, Columbus, Ohio, USA; Department of Cancer Biology and Genetics, Ohio State University, Columbus, Ohio, USA
| | - D Lev
- Surgery B, Sheba Medical Center, Tel Aviv, Israel
| | - R E Pollock
- Department of Surgical Oncology, Ohio State University Wexner Medical Center, Columbus, Ohio, USA; The James Cancer Center, Ohio State University Wexner Medical Center, Columbus, Ohio, USA
| |
Collapse
|
35
|
Lopez G, Bayulkem K, Hallett M. Progressive supranuclear palsy (PSP): Richardson syndrome and other PSP variants. Acta Neurol Scand 2016; 134:242-9. [PMID: 27070344 DOI: 10.1111/ane.12546] [Citation(s) in RCA: 34] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 11/24/2015] [Indexed: 01/05/2023]
Abstract
Phenotypic heterogeneity of progressive supranuclear palsy (PSP) has been increasingly reported in the literature and can be the source of incorrect clinical diagnosis particularly in the early stages of the disease when the classically associated symptoms of early falls and supranuclear gaze palsy may not be apparent. In addition to Richardson syndrome (RS), several atypical clinical phenotypes have been described. Advances in genetic, neuroimaging, and biochemical/molecular technologies contribute to the identification of these clinical subtypes in the context of typical PSP pathological findings. Our goal is to review the phenomenology reported in the literature that is associated with confirmed histopathological changes consistent with a PSP diagnosis and to highlight the clinical spectrum of PSP. A systematic review of the literature in PubMed through July 2015 using MeSH terms and key words related to PSP was conducted. Articles describing PSP classifications, diagnostic criteria, and case reports were reviewed and summarized. Additional PSP phenotypes not seen in recent clinicopathological studies are included. These include primary lateral sclerosis, pallido-nigro-luysian degeneration, axonal dystrophy, and multiple system atrophy in the spectrum of atypical PSP variants beyond the traditionally classified PSP subtypes. This review is intended to help with the diagnostic challenges of atypical PSP variants. We believe that large multicenter clinicopathological studies will help expand our understanding of etiology and specific mechanisms of neurodegeneration and will aid in the appropriate interpretation of outcomes when conducting clinical and basic science research.
Collapse
Affiliation(s)
- G. Lopez
- Section on Molecular Neurogenetics; Medical Genetics Branch; NHGRI Intramural Research Program; National Institutes of Health; Bethesda MD USA
| | - K. Bayulkem
- Human Motor Control Section; National Institute of Neurological Disorders and Stroke; National Institutes of Health; Bethesda MD USA
| | - M. Hallett
- Human Motor Control Section; National Institute of Neurological Disorders and Stroke; National Institutes of Health; Bethesda MD USA
| |
Collapse
|
36
|
Abstract
A prospective study of 50 cases of pelvic varices is described. Clinical history, symptoms and signs are shown emphasizing the multiple pregnancies that enlarge the gonadal veins where a high pressure escape and retrograde flow explain the vulvar and inner and posterior thigh and leg varicosities. A surgical procedure comprising resection of the gonadal veins and ligation of communicating veins to the uterine veins combined with vulvar and leg varicectomy have given excellent and encouraging early results.
Collapse
Affiliation(s)
| | - A. Alvarez
- Department of Radiology, Central Military Hospital and Medical School, Bogota, Colombia
| | | |
Collapse
|
37
|
Torregrosa L, Lopez G, Bouquet A. Antibiotic Sensitivity of Grapevine: A Comparison Between the Effect of Hygromycin and Kanamycin on Shoot Development of Transgenic 110 Richter Rootstock (Vi tis B erlandieri x Vi tis rupestris). S AFR J ENOL VITIC 2016. [DOI: 10.21548/21-1-2185] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
|
38
|
Hollowell AC, Regus JU, Gano KA, Bantay R, Centeno D, Pham J, Lyu JY, Moore D, Bernardo A, Lopez G, Patil A, Patel S, Lii Y, Sachs JL. Epidemic Spread of Symbiotic and Non-Symbiotic Bradyrhizobium Genotypes Across California. Microb Ecol 2016; 71:700-710. [PMID: 26467244 DOI: 10.1007/s00248-015-0685-5] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/08/2015] [Accepted: 09/28/2015] [Indexed: 06/05/2023]
Abstract
The patterns and drivers of bacterial strain dominance remain poorly understood in natural populations. Here, we cultured 1292 Bradyrhizobium isolates from symbiotic root nodules and the soil root interface of the host plant Acmispon strigosus across a >840-km transect in California. To investigate epidemiology and the potential role of accessory loci as epidemic drivers, isolates were genotyped at two chromosomal loci and were assayed for presence or absence of accessory "symbiosis island" loci that encode capacity to form nodules on hosts. We found that Bradyrhizobium populations were very diverse but dominated by few haplotypes-with a single "epidemic" haplotype constituting nearly 30 % of collected isolates and spreading nearly statewide. In many Bradyrhizobium lineages, we inferred presence and absence of the symbiosis island suggesting recurrent evolutionary gain and or loss of symbiotic capacity. We did not find statistical phylogenetic evidence that the symbiosis island acquisition promotes strain dominance and both symbiotic and non-symbiotic strains exhibited population dominance and spatial spread. Our dataset reveals that a strikingly few Bradyrhizobium genotypes can rapidly spread to dominate a landscape and suggests that these epidemics are not driven by the acquisition of accessory loci as occurs in key human pathogens.
Collapse
Affiliation(s)
- A C Hollowell
- Department of Biology, University of California, Riverside, CA, 92521, USA
| | - J U Regus
- Department of Biology, University of California, Riverside, CA, 92521, USA
| | - K A Gano
- Department of Biology, University of California, Riverside, CA, 92521, USA
| | - R Bantay
- Department of Biology, University of California, Riverside, CA, 92521, USA
| | - D Centeno
- Department of Biology, University of California, Riverside, CA, 92521, USA
| | - J Pham
- Department of Biology, University of California, Riverside, CA, 92521, USA
| | - J Y Lyu
- Department of Biology, University of California, Riverside, CA, 92521, USA
| | - D Moore
- Department of Biology, University of California, Riverside, CA, 92521, USA
| | - A Bernardo
- Department of Biology, University of California, Riverside, CA, 92521, USA
| | - G Lopez
- Department of Biology, University of California, Riverside, CA, 92521, USA
| | - A Patil
- Department of Biology, University of California, Riverside, CA, 92521, USA
| | - S Patel
- Department of Biology, University of California, Riverside, CA, 92521, USA
| | - Y Lii
- Department of Biology, University of California, Riverside, CA, 92521, USA
| | - J L Sachs
- Department of Biology, University of California, Riverside, CA, 92521, USA.
- Institute for Integrative Genome Biology, University of California, Riverside, CA, 95616, USA.
| |
Collapse
|
39
|
Flower R, Schoeman E, Liew YW, Condon J, Powley T, Lopez G, Hogan C, Hyland C. Massively parallel sequencing in complex blood group investigations: Resolving the previously unresolvable. Pathology 2016. [DOI: 10.1016/j.pathol.2015.12.278] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
40
|
Arregi A, Lopez G, Amutio M, Barbarias I, Bilbao J, Olazar M. Hydrogen production from biomass by continuous fast pyrolysis and in-line steam reforming. RSC Adv 2016. [DOI: 10.1039/c6ra01657j] [Citation(s) in RCA: 85] [Impact Index Per Article: 10.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
Abstract
The continuous fast pyrolysis of pine wood sawdust has been studied in a conical spouted bed reactor (CSBR) followed by in-line steam reforming of the pyrolysis vapours in a fluidised bed reactor on a Ni commercial catalyst.
Collapse
Affiliation(s)
- A. Arregi
- Department of Chemical Engineering
- University of the Basque Country UPV/EHU
- E48080 Bilbao
- Spain
| | - G. Lopez
- Department of Chemical Engineering
- University of the Basque Country UPV/EHU
- E48080 Bilbao
- Spain
| | - M. Amutio
- Department of Chemical Engineering
- University of the Basque Country UPV/EHU
- E48080 Bilbao
- Spain
| | - I. Barbarias
- Department of Chemical Engineering
- University of the Basque Country UPV/EHU
- E48080 Bilbao
- Spain
| | - J. Bilbao
- Department of Chemical Engineering
- University of the Basque Country UPV/EHU
- E48080 Bilbao
- Spain
| | - M. Olazar
- Department of Chemical Engineering
- University of the Basque Country UPV/EHU
- E48080 Bilbao
- Spain
| |
Collapse
|
41
|
Lopez G. EMDR : une technique de prise en charge dans un cadre psychothérapeutique et victimologique précis. Eur Psychiatry 2015. [DOI: 10.1016/j.eurpsy.2015.09.406] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
Abstract
Six millions de français ont subi l’inceste selon un sondage réalisé par la Sofres pour l’Association internationale des victimes de l’inceste en 2006. Dix pour cent des enfants sont maltraités dans les pays à hauts revenus. Les troubles que génèrent ces maltraitances, dont l’inceste est la forme la plus sévère, sont l’objet d’un puissant déni qui pourrait être levé en posant systémiquement la question de sa survenue, ce qui nécessite une connaissance minimum de la psychotraumatologie et de la victimologie. L’adulte jeune victime d’inceste présente dans la forme typique un trouble de la personnalité qui se manifeste par : des difficultés à gérer les émotions avec des troubles dissociatifs ; un manque totale de confiance en soi et en toute forme d’aide possible, thérapeutique notamment ; des symptômes comorbides écrans ; une tendance à la répétition littérale du scénario traumatique, notamment dans la relation qui s’instaure avec le thérapeute (transfert et contre-transfert traumatique). Le thérapeute doit mettre en place un cadre thérapeutique qui permet la réécriture de scénario traumatique : recherche systématique de maltraitances infantiles ; rappel de la loi et incitation à porter plainte ; travail en réseau en non pas colloque singulier ; négociation « démocratique » du cadre thérapeutique ; critique du système agresseur qui entretient le déni ; contrôle des contre attitudes de rejet qui affectent les thérapies ; absence de passage. Dans ce contexte relationnel, l’EMDR est une technique qui permet de traiter certains symptômes et, notamment, les intrusions psychotraumatiques caractéristiques de la plupart des troubles psychotraumatiques.
Collapse
|
42
|
Roda D, Castillo J, Telechea M, Gil A, Lopez G, Franco L, González-Rodriguez P, Roselló S, Fidalgo JP, Garcia-Trevijano ERY, Zaragozá R, Cervantes A. 152 EGF-induced acetylation of heterogeneous nuclear ribonucleoproteins is dependent on KRAS mutational status in colorectal cancer cells. Eur J Cancer 2015. [DOI: 10.1016/s0959-8049(16)30050-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
43
|
Bouyoucef SE, Uusitalo V, Kamperidis V, De Graaf M, Maaniitty T, Stenstrom I, Broersen A, Scholte A, Saraste A, Bax J, Knuuti J, Furuhashi T, Moroi M, Awaya T, Masai H, Minakawa M, Kunimasa T, Fukuda H, Sugi K, Berezin A, Kremzer A, Clerc O, Kaufmann B, Possner M, Liga R, Vontobel J, Mikulicic F, Graeni C, Benz D, Kaufmann P, Buechel R, Ferreira M, Cunha M, Albuquerque A, Ramos D, Costa G, Lima J, Pego M, Peix A, Cisneros L, Cabrera L, Padron K, Rodriguez L, Heres F, Carrillo R, Mena E, Fernandez Y, Huizing E, Van Dijk J, Van Dalen J, Timmer J, Ottervanger J, Slump C, Jager P, Venuraju S, Jeevarethinam A, Yerramasu A, Atwal S, Mehta V, Lahiri A, Arjonilla Lopez A, Calero Rueda MJ, Gallardo G, Fernandez-Cuadrado J, Hernandez Aceituno D, Sanchez Hernandez J, Yoshida H, Mizukami A, Matsumura A, Smettei O, Abazid R, Sayed S, Mlynarska A, Mlynarski R, Golba K, Sosnowski M, Winther S, Svensson M, Jorgensen H, Bouchelouche K, Gormsen L, Holm N, Botker H, Ivarsen P, Bottcher M, Cortes CM, Aramayo G E, Daicz M, Casuscelli J, Alaguibe E, Neira Sepulveda A, Cerda M, Ganum G, Embon M, Vigne J, Enilorac B, Lebasnier A, Valancogne L, Peyronnet D, Manrique A, Agostini D, Menendez D, Rajpal S, Kocherla C, Acharya M, Reddy P, Sazonova I, Ilushenkova Y, Batalov R, Rogovskaya Y, Lishmanov Y, Popov S, Varlamova N, Prado Diaz S, Jimenez Rubio C, Gemma D, Refoyo Salicio E, Valbuena Lopez S, Moreno Yanguela M, Torres M, Fernandez-Velilla M, Lopez-Sendon J, Guzman Martinez G, Puente A, Rosales S, Martinez C, Cabada M, Melendez G, Ferreira R, Gonzaga A, Santos J, Vijayan S, Smith S, Smith M, Muthusamy R, Takeishi Y, Oikawa M, Goral JL, Napoli J, Montana O, Damico A, Quiroz M, Damico A, Forcada P, Schmidberg J, Zucchiatti N, Olivieri D, Jeevarethinam A, Venuraju S, Dumo A, Ruano S, Rakhit R, Davar J, Nair D, Cohen M, Darko D, Lahiri A, Yokota S, Ottervanger J, Maas A, Mouden M, Timmer J, Knollema S, Jager P, Sanja Mazic S, Lazovic B, Marina Djelic M, Jelena Suzic Lazic J, Tijana Acimovic T, Milica Deleva M, Vesnina Z, Zafrir N, Bental T, Mats I, Solodky A, Gutstein A, Hasid Y, Belzer D, Kornowski R, Ben Said R, Ben Mansour N, Ibn Haj Amor H, Chourabi C, Hagui A, Fehri W, Hawala H, Shugushev Z, Patrikeev A, Maximkin D, Chepurnoy A, Kallianpur V, Mambetov A, Dokshokov G, Teresinska A, Wozniak O, Maciag A, Wnuk J, Dabrowski A, Czerwiec A, Jezierski J, Biernacka K, Robinson J, Prosser J, Cheung G, Allan S, Mcmaster G, Reid S, Tarbuck A, Martin W, Queiroz R, Falcao A, Giorgi M, Imada R, Nogueira S, Chalela W, Kalil Filho R, Meneghetti W, Matveev V, Bubyenov A, Podzolkov V, Shugushev Z, Maximkin D, Chepurnoy A, Baranovich V, Faibushevich A, Kolzhecova Y, Volkova O, Kallianpur V, Peix A, Cabrera L, Padron K, Rodriguez L, Fernandez J, Lopez G, Mena E, Fernandez Y, Dondi M, Paez D, Butcher C, Reyes E, Al-Housni M, Green R, Santiago H, Ghiotto F, Hinton-Taylor S, Pottle A, Mason M, Underwood S, Casans Tormo I, Diaz-Exposito R, Plancha-Burguera E, Elsaban K, Alsakhri H, Yoshinaga K, Ochi N, Tomiyama Y, Katoh C, Inoue M, Nishida M, Suzuki E, Manabe O, Ito Y, Tamaki N, Tahilyani A, Jafary F, Ho Hee Hwa H, Ozdemir S, Kirilmaz B, Barutcu A, Tan Y, Celik F, Sakgoz S, Cabada Gamboa M, Puente Barragan A, Morales Vitorino N, Medina Servin M, Hindorf C, Akil S, Hedeer F, Jogi J, Engblom H, Martire V, Pis Diez E, Martire M, Portillo D, Hoff C, Balche A, Majgaard J, Tolbod L, Harms H, Bouchelouche K, Soerensen J, Froekiaer J, Gormsen L, Nudi F, Neri G, Procaccini E, Pinto A, Vetere M, Biondi-Zoccai G, Falcao A, Chalela W, Giorgi M, Imada R, Soares J, Do Val R, Oliveira M, Kalil Filho R, Meneghetti J, Tekabe Y, Anthony T, Li Q, Schmidt A, Johnson L, Groenman M, Tarkia M, Kakela M, Halonen P, Kiviniemi T, Pietila M, Yla-Herttuala S, Knuuti J, Roivainen A, Saraste A, Nekolla S, Swirzek S, Higuchi T, Reder S, Schachoff S, Bschorner M, Laitinen I, Robinson S, Yousefi B, Schwaiger M, Kero T, Lindsjo L, Antoni G, Westermark P, Carlson K, Wikstrom G, Sorensen J, Lubberink M, Rouzet F, Cognet T, Guedj K, Morvan M, El Shoukr F, Louedec L, Choqueux C, Nicoletti A, Le Guludec D, Jimenez-Heffernan A, Munoz-Beamud F, Sanchez De Mora E, Borrachero C, Salgado C, Ramos-Font C, Lopez-Martin J, Hidalgo M, Lopez-Aguilar R, Soriano E, Okizaki A, Nakayama M, Ishitoya S, Sato J, Takahashi K, Burchert I, Caobelli F, Wollenweber T, Nierada M, Fulsche J, Dieckmann C, Bengel F, Shuaib S, Mahlum D, Port S, Gemma D, Refoyo E, Cuesta E, Guzman G, Lopez T, Valbuena S, Fernandez-Velilla M, Del Prado S, Moreno M, Lopez-Sendon J, Harbinson M, Donnelly L, Einstein AJ, Johnson LL, Deluca AJ, Kontak AC, Groves DW, Stant J, Pozniakoff T, Cheng B, Rabbani LE, Bokhari S, Caobelli F, Schuetze C, Nierada M, Fulsche J, Dieckmann C, Bengel F, Aguade-Bruix S, Pizzi M, Romero-Farina G, Terricabras M, Villasboas D, Castell-Conesa J, Candell-Riera J, Brunner S, Gross L, Todica A, Lehner S, Di Palo A, Niccoli Asabella A, Magarelli C, Notaristefano A, Ferrari C, Rubini G, Sellem A, Melki S, Elajmi W, Hammami H, Ziadi M, Montero J, Ameriso J, Villavicencio R, Benito Gonzalez TF, Mayorga Bajo A, Gutierrez Caro R, Rodriguez Santamarta M, Alvarez Roy L, Martinez Paz E, Barinaga Martin C, Martin Fernandez J, Alonso Rodriguez D, Iglesias Garriz I, Gemma D, Refoyo E, Cuesta E, Guzman G, Valbuena S, Rosillo S, Del Prado S, Torres M, Moreno M, Lopez-Sendon J, Taleb S, Cherkaoui Salhi G, Regbaoui Y, Ait Idir M, Guensi A, Puente A, Rosales S, Martinez C, Cabada M, Benito Gonzalez TF, Mayorga Bajo A, Gutierrez Caro R, Rodriguez Santamarta M, Alvarez Roy L, Martinez Paz E, Martin Lopez CE, Castano Ruiz M, Martin Fernandez J, Iglesias Garriz I. Poster Session 2: Monday 4 May 2015, 08:00-18:00 * Room: Poster Area. Eur Heart J Cardiovasc Imaging 2015. [DOI: 10.1093/ehjci/jev052] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
44
|
Carmona P, Gayán MJ, Lopez G, Lizardi A, Iribarren J, Von Wichmann M, Ercilla M, Ripa C, Lombera L, Bachiller MP. CP-082 Difference in effectiveness and safety of triple therapy-based treatment between Mono and Co-infected hepatitis C patients. Eur J Hosp Pharm 2015. [DOI: 10.1136/ejhpharm-2015-000639.78] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022] Open
|
45
|
Feng H, Lopez G, Kim CK, Alvarez A, Duncan C, Nishikawa R, Nagane M, Su AJ, Hedberg M, Grandis J, Raizer J, Gao WQ, Kim SH, Minata M, Nakano I, Lin HK, Furnari F, Cavenee W, Hu B, Cheng SY. CS-06 * EGFR PHOSPHORYLATION OF DCBLD2 RECRUITS TRAF6 AND STIMULATES Akt-PROMOTED TUMORIGENESIS. Neuro Oncol 2014. [DOI: 10.1093/neuonc/nou242.6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
46
|
Artetxe M, Lopez G, Amutio M, Bilbao J, Olazar M. Kinetic modelling of the cracking of HDPE pyrolysis volatiles on a HZSM-5 zeolite based catalyst. Chem Eng Sci 2014. [DOI: 10.1016/j.ces.2014.05.044] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
47
|
Litos M, Abe K, Hayato Y, Iida T, Ikeda M, Iyogi K, Kameda J, Kobayashi K, Koshio Y, Kozuma Y, Miura M, Moriyama S, Nakahata M, Nakayama S, Obayashi Y, Ogawa H, Sekiya H, Shiozawa M, Suzuki Y, Takeda A, Takenaga Y, Takeuchi Y, Ueno K, Ueshima K, Watanabe H, Yamada S, Yokozawa T, Hazama S, Ishihara C, Kaji H, Kajita T, Kaneyuki K, McLachlan T, Okumura K, Shimizu Y, Tanimoto N, Vagins MR, Kearns E, Stone JL, Sulak LR, Dufour F, Raaf JL, Henning B, Goldhaber M, Bays K, Casper D, Cravens JP, Kropp WR, Mine S, Regis C, Smy MB, Sobel HW, Ganezer KS, Hill J, Keig WE, Jang JS, Kim JY, Lim IT, Albert JB, Wongjirad T, Wendell R, Scholberg K, Walter CW, Tasaka S, Learned JG, Matsuno S, Watanabe Y, Hasegawa T, Ishida T, Ishii T, Kobayashi T, Nakadaira T, Nakamura K, Nishikawa K, Nishino H, Oyama Y, Sakashita K, Sekiguchi T, Tsukamoto T, Suzuki AT, Minamino A, Nakaya T, Fukuda Y, Itow Y, Mitsuka G, Tanaka T, Jung CK, Lopez G, McGrew C, Terri R, Yanagisawa C, Tamura N, Ishino H, Kibayashi A, Mino S, Mori T, Sakuda M, Toyota H, Kuno Y, Yoshida M, Kim SB, Yang BS, Ishizuka T, Okazawa H, Choi Y, Nishijima K, Yokosawa Y, Koshiba M, Yokoyama M, Totsuka Y, Chen S, Heng Y, Yang Z, Zhang H, Kielczewska D, Mijakowski P, Connolly K, Dziomba M, Thrane E, Wilkes RJ. Search for dinucleon decay into kaons in Super-Kamiokande. Phys Rev Lett 2014; 112:131803. [PMID: 24745406 DOI: 10.1103/physrevlett.112.131803] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/10/2013] [Indexed: 06/03/2023]
Abstract
A search for the dinucleon decay pp → K+ K+ has been performed using 91.6 kton·yr data from Super-Kamiokande-I. This decay provides a sensitive probe of the R-parity-violating parameter λ112''. A boosted decision tree analysis found no signal candidates in the data. The expected background was 0.28±0.19 atmospheric neutrino induced events and the estimated signal detection efficiency was 12.6%±3.2%. A lower limit of 1.7×10(32) years has been placed on the partial lifetime of the decay O16 → C14K+ K+ at 90% C.L. A corresponding upper limit of 7.8×10(-9) has been placed on the parameter λ112''.
Collapse
Affiliation(s)
- M Litos
- Department of Physics, Boston University, Boston, Massachusetts 02215, USA
| | - K Abe
- Kamioka Observatory, Institute for Cosmic Ray Research, University of Tokyo, Kamioka, Gifu 506-1205, Japan
| | - Y Hayato
- Kamioka Observatory, Institute for Cosmic Ray Research, University of Tokyo, Kamioka, Gifu 506-1205, Japan and Institute for the Physics and Mathematics of the Universe (WPI), University of Tokyo, Kashiwa, Chiba 277-8583, Japan
| | - T Iida
- Kamioka Observatory, Institute for Cosmic Ray Research, University of Tokyo, Kamioka, Gifu 506-1205, Japan
| | - M Ikeda
- Kamioka Observatory, Institute for Cosmic Ray Research, University of Tokyo, Kamioka, Gifu 506-1205, Japan
| | - K Iyogi
- Kamioka Observatory, Institute for Cosmic Ray Research, University of Tokyo, Kamioka, Gifu 506-1205, Japan
| | - J Kameda
- Kamioka Observatory, Institute for Cosmic Ray Research, University of Tokyo, Kamioka, Gifu 506-1205, Japan
| | - K Kobayashi
- Kamioka Observatory, Institute for Cosmic Ray Research, University of Tokyo, Kamioka, Gifu 506-1205, Japan
| | - Y Koshio
- Kamioka Observatory, Institute for Cosmic Ray Research, University of Tokyo, Kamioka, Gifu 506-1205, Japan
| | - Y Kozuma
- Kamioka Observatory, Institute for Cosmic Ray Research, University of Tokyo, Kamioka, Gifu 506-1205, Japan
| | - M Miura
- Kamioka Observatory, Institute for Cosmic Ray Research, University of Tokyo, Kamioka, Gifu 506-1205, Japan
| | - S Moriyama
- Kamioka Observatory, Institute for Cosmic Ray Research, University of Tokyo, Kamioka, Gifu 506-1205, Japan and Institute for the Physics and Mathematics of the Universe (WPI), University of Tokyo, Kashiwa, Chiba 277-8583, Japan
| | - M Nakahata
- Kamioka Observatory, Institute for Cosmic Ray Research, University of Tokyo, Kamioka, Gifu 506-1205, Japan and Institute for the Physics and Mathematics of the Universe (WPI), University of Tokyo, Kashiwa, Chiba 277-8583, Japan
| | - S Nakayama
- Kamioka Observatory, Institute for Cosmic Ray Research, University of Tokyo, Kamioka, Gifu 506-1205, Japan
| | - Y Obayashi
- Kamioka Observatory, Institute for Cosmic Ray Research, University of Tokyo, Kamioka, Gifu 506-1205, Japan
| | - H Ogawa
- Kamioka Observatory, Institute for Cosmic Ray Research, University of Tokyo, Kamioka, Gifu 506-1205, Japan
| | - H Sekiya
- Kamioka Observatory, Institute for Cosmic Ray Research, University of Tokyo, Kamioka, Gifu 506-1205, Japan
| | - M Shiozawa
- Kamioka Observatory, Institute for Cosmic Ray Research, University of Tokyo, Kamioka, Gifu 506-1205, Japan and Institute for the Physics and Mathematics of the Universe (WPI), University of Tokyo, Kashiwa, Chiba 277-8583, Japan
| | - Y Suzuki
- Kamioka Observatory, Institute for Cosmic Ray Research, University of Tokyo, Kamioka, Gifu 506-1205, Japan and Institute for the Physics and Mathematics of the Universe (WPI), University of Tokyo, Kashiwa, Chiba 277-8583, Japan
| | - A Takeda
- Kamioka Observatory, Institute for Cosmic Ray Research, University of Tokyo, Kamioka, Gifu 506-1205, Japan
| | - Y Takenaga
- Kamioka Observatory, Institute for Cosmic Ray Research, University of Tokyo, Kamioka, Gifu 506-1205, Japan
| | - Y Takeuchi
- Kamioka Observatory, Institute for Cosmic Ray Research, University of Tokyo, Kamioka, Gifu 506-1205, Japan and Institute for the Physics and Mathematics of the Universe (WPI), University of Tokyo, Kashiwa, Chiba 277-8583, Japan
| | - K Ueno
- Kamioka Observatory, Institute for Cosmic Ray Research, University of Tokyo, Kamioka, Gifu 506-1205, Japan
| | - K Ueshima
- Kamioka Observatory, Institute for Cosmic Ray Research, University of Tokyo, Kamioka, Gifu 506-1205, Japan
| | - H Watanabe
- Kamioka Observatory, Institute for Cosmic Ray Research, University of Tokyo, Kamioka, Gifu 506-1205, Japan
| | - S Yamada
- Kamioka Observatory, Institute for Cosmic Ray Research, University of Tokyo, Kamioka, Gifu 506-1205, Japan
| | - T Yokozawa
- Kamioka Observatory, Institute for Cosmic Ray Research, University of Tokyo, Kamioka, Gifu 506-1205, Japan
| | - S Hazama
- Research Center for Cosmic Neutrinos, Institute for Cosmic Ray Research, University of Tokyo, Kashiwa, Chiba 277-8582, Japan
| | - C Ishihara
- Research Center for Cosmic Neutrinos, Institute for Cosmic Ray Research, University of Tokyo, Kashiwa, Chiba 277-8582, Japan
| | - H Kaji
- Research Center for Cosmic Neutrinos, Institute for Cosmic Ray Research, University of Tokyo, Kashiwa, Chiba 277-8582, Japan
| | - T Kajita
- Institute for the Physics and Mathematics of the Universe (WPI), University of Tokyo, Kashiwa, Chiba 277-8583, Japan and Research Center for Cosmic Neutrinos, Institute for Cosmic Ray Research, University of Tokyo, Kashiwa, Chiba 277-8582, Japan
| | - K Kaneyuki
- Institute for the Physics and Mathematics of the Universe (WPI), University of Tokyo, Kashiwa, Chiba 277-8583, Japan and Research Center for Cosmic Neutrinos, Institute for Cosmic Ray Research, University of Tokyo, Kashiwa, Chiba 277-8582, Japan
| | - T McLachlan
- Research Center for Cosmic Neutrinos, Institute for Cosmic Ray Research, University of Tokyo, Kashiwa, Chiba 277-8582, Japan
| | - K Okumura
- Research Center for Cosmic Neutrinos, Institute for Cosmic Ray Research, University of Tokyo, Kashiwa, Chiba 277-8582, Japan
| | - Y Shimizu
- Research Center for Cosmic Neutrinos, Institute for Cosmic Ray Research, University of Tokyo, Kashiwa, Chiba 277-8582, Japan
| | - N Tanimoto
- Research Center for Cosmic Neutrinos, Institute for Cosmic Ray Research, University of Tokyo, Kashiwa, Chiba 277-8582, Japan
| | - M R Vagins
- Institute for the Physics and Mathematics of the Universe (WPI), University of Tokyo, Kashiwa, Chiba 277-8583, Japan and Department of Physics and Astronomy, University of California, Irvine, Irvine, California 92697-4575, USA
| | - E Kearns
- Department of Physics, Boston University, Boston, Massachusetts 02215, USA and Institute for the Physics and Mathematics of the Universe (WPI), University of Tokyo, Kashiwa, Chiba 277-8583, Japan
| | - J L Stone
- Department of Physics, Boston University, Boston, Massachusetts 02215, USA and Institute for the Physics and Mathematics of the Universe (WPI), University of Tokyo, Kashiwa, Chiba 277-8583, Japan
| | - L R Sulak
- Department of Physics, Boston University, Boston, Massachusetts 02215, USA
| | - F Dufour
- Department of Physics, Boston University, Boston, Massachusetts 02215, USA
| | - J L Raaf
- Department of Physics, Boston University, Boston, Massachusetts 02215, USA
| | - B Henning
- Department of Physics, Boston University, Boston, Massachusetts 02215, USA
| | - M Goldhaber
- Physics Department, Brookhaven National Laboratory, Upton, New York 11973, USA
| | - K Bays
- Department of Physics and Astronomy, University of California, Irvine, Irvine, California 92697-4575, USA
| | - D Casper
- Department of Physics and Astronomy, University of California, Irvine, Irvine, California 92697-4575, USA
| | - J P Cravens
- Department of Physics and Astronomy, University of California, Irvine, Irvine, California 92697-4575, USA
| | - W R Kropp
- Department of Physics and Astronomy, University of California, Irvine, Irvine, California 92697-4575, USA
| | - S Mine
- Department of Physics and Astronomy, University of California, Irvine, Irvine, California 92697-4575, USA
| | - C Regis
- Department of Physics and Astronomy, University of California, Irvine, Irvine, California 92697-4575, USA
| | - M B Smy
- Institute for the Physics and Mathematics of the Universe (WPI), University of Tokyo, Kashiwa, Chiba 277-8583, Japan and Department of Physics and Astronomy, University of California, Irvine, Irvine, California 92697-4575, USA
| | - H W Sobel
- Institute for the Physics and Mathematics of the Universe (WPI), University of Tokyo, Kashiwa, Chiba 277-8583, Japan and Department of Physics and Astronomy, University of California, Irvine, Irvine, California 92697-4575, USA
| | - K S Ganezer
- Department of Physics, California State University, Dominguez Hills, Carson, California 90747, USA
| | - J Hill
- Department of Physics, California State University, Dominguez Hills, Carson, California 90747, USA
| | - W E Keig
- Department of Physics, California State University, Dominguez Hills, Carson, California 90747, USA
| | - J S Jang
- Department of Physics, Chonnam National University, Kwangju 500-757, Korea
| | - J Y Kim
- Department of Physics, Chonnam National University, Kwangju 500-757, Korea
| | - I T Lim
- Department of Physics, Chonnam National University, Kwangju 500-757, Korea
| | - J B Albert
- Department of Physics, Duke University, Durham, North Carolina 27708, USA
| | - T Wongjirad
- Department of Physics, Duke University, Durham, North Carolina 27708, USA
| | - R Wendell
- Department of Physics, Duke University, Durham, North Carolina 27708, USA
| | - K Scholberg
- Institute for the Physics and Mathematics of the Universe (WPI), University of Tokyo, Kashiwa, Chiba 277-8583, Japan and Department of Physics, Duke University, Durham, North Carolina 27708, USA
| | - C W Walter
- Institute for the Physics and Mathematics of the Universe (WPI), University of Tokyo, Kashiwa, Chiba 277-8583, Japan and Department of Physics, Duke University, Durham, North Carolina 27708, USA
| | - S Tasaka
- Department of Physics, Gifu University, Gifu, Gifu 501-1193, Japan
| | - J G Learned
- Department of Physics and Astronomy, University of Hawaii, Honolulu, Hawaii 96822, USA
| | - S Matsuno
- Department of Physics and Astronomy, University of Hawaii, Honolulu, Hawaii 96822, USA
| | - Y Watanabe
- Physics Division, Department of Engineering, Kanagawa University, Kanagawa, Yokohama 221-8686, Japan
| | - T Hasegawa
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki 305-0801, Japan
| | - T Ishida
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki 305-0801, Japan
| | - T Ishii
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki 305-0801, Japan
| | - T Kobayashi
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki 305-0801, Japan
| | - T Nakadaira
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki 305-0801, Japan
| | - K Nakamura
- Institute for the Physics and Mathematics of the Universe (WPI), University of Tokyo, Kashiwa, Chiba 277-8583, Japan and High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki 305-0801, Japan
| | - K Nishikawa
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki 305-0801, Japan
| | - H Nishino
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki 305-0801, Japan
| | - Y Oyama
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki 305-0801, Japan
| | - K Sakashita
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki 305-0801, Japan
| | - T Sekiguchi
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki 305-0801, Japan
| | - T Tsukamoto
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki 305-0801, Japan
| | - A T Suzuki
- Department of Physics, Kobe University, Kobe, Hyogo 657-8501, Japan
| | - A Minamino
- Department of Physics, Kyoto University, Kyoto, Kyoto 606-8502, Japan
| | - T Nakaya
- Institute for the Physics and Mathematics of the Universe (WPI), University of Tokyo, Kashiwa, Chiba 277-8583, Japan and Department of Physics, Kyoto University, Kyoto, Kyoto 606-8502, Japan
| | - Y Fukuda
- Department of Physics, Miyagi University of Education, Sendai, Miyagi 980-0845, Japan
| | - Y Itow
- Solar Terrestrial Environment Laboratory, Nagoya University, Nagoya, Aichi 464-8602, Japan
| | - G Mitsuka
- Solar Terrestrial Environment Laboratory, Nagoya University, Nagoya, Aichi 464-8602, Japan
| | - T Tanaka
- Solar Terrestrial Environment Laboratory, Nagoya University, Nagoya, Aichi 464-8602, Japan
| | - C K Jung
- Department of Physics and Astronomy, State University of New York, Stony Brook, New York 11794-3800, USA
| | - G Lopez
- Department of Physics and Astronomy, State University of New York, Stony Brook, New York 11794-3800, USA
| | - C McGrew
- Department of Physics and Astronomy, State University of New York, Stony Brook, New York 11794-3800, USA
| | - R Terri
- Department of Physics and Astronomy, State University of New York, Stony Brook, New York 11794-3800, USA
| | - C Yanagisawa
- Department of Physics and Astronomy, State University of New York, Stony Brook, New York 11794-3800, USA
| | - N Tamura
- Department of Physics, Niigata University, Niigata, Niigata 950-2181, Japan
| | - H Ishino
- Department of Physics, Okayama University, Okayama, Okayama 700-8530, Japan
| | - A Kibayashi
- Department of Physics, Okayama University, Okayama, Okayama 700-8530, Japan
| | - S Mino
- Department of Physics, Okayama University, Okayama, Okayama 700-8530, Japan
| | - T Mori
- Department of Physics, Okayama University, Okayama, Okayama 700-8530, Japan
| | - M Sakuda
- Department of Physics, Okayama University, Okayama, Okayama 700-8530, Japan
| | - H Toyota
- Department of Physics, Okayama University, Okayama, Okayama 700-8530, Japan
| | - Y Kuno
- Department of Physics, Osaka University, Toyonaka, Osaka 560-0043, Japan
| | - M Yoshida
- Department of Physics, Osaka University, Toyonaka, Osaka 560-0043, Japan
| | - S B Kim
- Department of Physics, Seoul National University, Seoul 151-742, Korea
| | - B S Yang
- Department of Physics, Seoul National University, Seoul 151-742, Korea
| | - T Ishizuka
- Department of Systems Engineering, Shizuoka University, Hamamatsu, Shizuoka 432-8561, Japan
| | - H Okazawa
- Department of Informatics in Social Welfare, Shizuoka University of Welfare, Yaizu, Shizuoka 425-8611, Japan
| | - Y Choi
- Department of Physics, Sungkyunkwan University, Suwon 440-746, Korea
| | - K Nishijima
- Department of Physics, Tokai University, Hiratsuka, Kanagawa 259-1292, Japan
| | - Y Yokosawa
- Department of Physics, Tokai University, Hiratsuka, Kanagawa 259-1292, Japan
| | - M Koshiba
- The University of Tokyo, Bunkyo, Tokyo 113-0033, Japan
| | - M Yokoyama
- The University of Tokyo, Bunkyo, Tokyo 113-0033, Japan
| | - Y Totsuka
- The University of Tokyo, Bunkyo, Tokyo 113-0033, Japan
| | - S Chen
- Department of Engineering Physics, Tsinghua University, Beijing 100084, China
| | - Y Heng
- Department of Engineering Physics, Tsinghua University, Beijing 100084, China
| | - Z Yang
- Department of Engineering Physics, Tsinghua University, Beijing 100084, China
| | - H Zhang
- Department of Engineering Physics, Tsinghua University, Beijing 100084, China
| | - D Kielczewska
- Institute of Experimental Physics, Warsaw University, 00-681 Warsaw, Poland
| | - P Mijakowski
- Institute of Experimental Physics, Warsaw University, 00-681 Warsaw, Poland
| | - K Connolly
- Department of Physics, University of Washington, Seattle, Washington 98195-1560, USA
| | - M Dziomba
- Department of Physics, University of Washington, Seattle, Washington 98195-1560, USA
| | - E Thrane
- Department of Physics, University of Washington, Seattle, Washington 98195-1560, USA
| | - R J Wilkes
- Department of Physics, University of Washington, Seattle, Washington 98195-1560, USA
| |
Collapse
|
48
|
Lockyer A, Oram R, Lutchminarain N, Lopez G, Meek S. Patterns of injury in penetrating sharp trauma in a Provincial KwaZulu-Natal Hospital. Afr J Emerg Med 2013. [DOI: 10.1016/j.afjem.2013.08.013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022] Open
|
49
|
Altzibar H, Lopez G, Estiati I, Bilbao J, Olazar M. Particle Cycle Times and Solid Circulation Rates in Conical Spouted Beds with Draft Tubes of Different Configuration. Ind Eng Chem Res 2013. [DOI: 10.1021/ie401412j] [Citation(s) in RCA: 33] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- H. Altzibar
- Department
of Chemical Engineering, University of the Basque Country, PO Box 64, E48080 Bilbao, Spain
| | - G. Lopez
- Department
of Chemical Engineering, University of the Basque Country, PO Box 64, E48080 Bilbao, Spain
| | - I. Estiati
- Department
of Chemical Engineering, University of the Basque Country, PO Box 64, E48080 Bilbao, Spain
| | - J. Bilbao
- Department
of Chemical Engineering, University of the Basque Country, PO Box 64, E48080 Bilbao, Spain
| | - M. Olazar
- Department
of Chemical Engineering, University of the Basque Country, PO Box 64, E48080 Bilbao, Spain
| |
Collapse
|
50
|
Lobos E, Occhionero M, Werenitzky D, Fernandez J, Gonzalez LM, Rodriguez C, Calvo C, Lopez G, Oehlschlager AC. Optimization of a Trap for Tuta absoluta Meyrick (Lepidoptera: Gelechiidae) and Trials to Determine the Effectiveness of Mass Trapping. Neotrop Entomol 2013; 42:448-457. [PMID: 23949978 DOI: 10.1007/s13744-013-0141-5] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/25/2012] [Accepted: 05/08/2013] [Indexed: 06/02/2023]
Abstract
Management of the South American tomato leafminer, Tuta absoluta Meyrick, with insecticides has led to the widespread development of insect resistance. Mass trapping using traps baited with the female-produced sex pheromone is an attractive alternative for the management of this pest. The current study evaluated several commercial trap designs for capture of T. absoluta. Based on its small size and ease of handling, the most effective trap is a small plastic container with entry windows cut on the sides filled with motor oil over water. These traps are most effective when placed near ground level. Tests of septa containing 0.1 or 0.2 mg of the pheromone (95:5) E4, Z8-14Ac/E4,Z8,Z11-14Ac were slightly more attractive than septa loaded with 0.5, 1.0, or 2 mg during the first week of use, but the latter three loadings were slightly more attractive than the first two loadings after 9 weeks. Ideal trap baits were loaded with 0.5 mg of pheromone. Higher numbers of T. absoluta were captured near upwind borders of tomato fields suggesting that treatments against T. absoluta should be concentrated near upwind parts of fields. Comparisons of conventional insecticide treatment versus mass trapping to manage T. absoluta damage in three different test sites showed that even when initial captures in monitoring traps were high (>35 males trap(-1) day(-1)), mass trapping at 48 traps/ha reduced leaf damage more efficiently than conventional insecticide treatment. Based on the typical insecticide recommendations against T. absoluta, mass trapping is an economically viable alternative.
Collapse
Affiliation(s)
- E Lobos
- Fac de Agronomia y Agroindustrias, UNSE, Santiago del Estero, Argentina
| | - M Occhionero
- Fac de Agronomia y Agroindustrias, UNSE, Santiago del Estero, Argentina
| | - D Werenitzky
- Fac de Agronomia y Agroindustrias, UNSE, Santiago del Estero, Argentina
| | - J Fernandez
- Fac de Agronomia y Zootecnica, Univ de Tucumán, Tucumán, Argentina
| | - L M Gonzalez
- ChemTica Internacional, Apdo. 640-3100 Sto. Domingo, Heredia, Costa Rica, 40603
| | - C Rodriguez
- ChemTica Internacional, Apdo. 640-3100 Sto. Domingo, Heredia, Costa Rica, 40603
| | - C Calvo
- ChemTica Internacional, Apdo. 640-3100 Sto. Domingo, Heredia, Costa Rica, 40603
| | - G Lopez
- ChemTica Internacional, Apdo. 640-3100 Sto. Domingo, Heredia, Costa Rica, 40603
| | - A C Oehlschlager
- ChemTica Internacional, Apdo. 640-3100 Sto. Domingo, Heredia, Costa Rica, 40603.
| |
Collapse
|